Santa Clara University

Scholar Commons
Bioengineering Senior Theses

Engineering Senior Theses

6-2018

MilkGuard: Low-Cost, Polymer-based Sensor for
the Detection of Escherichia coli in Donated
Human Breast Milk
Maggie May
Santa Clara University, mmay@scu.edu

Nicholas Kikuchi
Santa Clara University, nkikuchi@scu.edu

Matthew Zweber
Santa Clara University, mzweber@scu.edu

Follow this and additional works at: https://scholarcommons.scu.edu/bioe_senior
Part of the Biomedical Engineering and Bioengineering Commons
Recommended Citation
May, Maggie; Kikuchi, Nicholas; and Zweber, Matthew, "MilkGuard: Low-Cost, Polymer-based Sensor for the Detection of
Escherichia coli in Donated Human Breast Milk" (2018). Bioengineering Senior Theses. 78.
https://scholarcommons.scu.edu/bioe_senior/78

This Thesis is brought to you for free and open access by the Engineering Senior Theses at Scholar Commons. It has been accepted for inclusion in
Bioengineering Senior Theses by an authorized administrator of Scholar Commons. For more information, please contact rscroggin@scu.edu.

MilkGuard: Low-Cost, Polymer-based Sensor for the Detection of Escherichia coli
in Donated Human Breast Milk
By
Maggie May, Nicholas Kikuchi, Matthew Zweber

SENIOR DESIGN PROJECT REPORT

Submitted to
Department of Bioengineering
SANTA CLARA UNIVERSITY

Partial Fulfillment of the Requirements for the degree of
Bachelor of Science in Bioengineering

Santa Clara, California
2018

1

ABSTRACT
Breast milk, the gold standard for infant nutrition, could prevent up to 13% of child
deaths worldwide. However, many mothers are unable to breastfeed due to health conditions and
other factors. Because of this, a network of more than 500+ human milk banks, which collect and
distribute donated breast milk to infants, have emerged worldwide. However, operational costs to
ensure the safety of this milk remain time-intensive and costly.
There are no existing diagnostics for rapid and on-site detection of bacterial contaminants
in donated milk. Currently, many milk banks send samples to outside laboratories for bacterial
culturing tests, which take 24-48 hours to receive results. In contrast, MilkGuard is an on-site
detection method which ensures results in hours rather than days. To determine whether or not
E.coli is present in donated milk, a drop of milk is deposited onto the sensor. If the milk is
contaminated, the sensor will turn a blue color due to an enzyme-substrate reaction of the
bacteria.
The goal of the project is to create a cost and rapid alternative to traditional bacterial
culturing testing to screen for E. coli bacteria in donated human breast milk. This will allow
users to ensure that milk samples are sterile enough to provide to young infants, while also
providing breast milk banks an alternative that will allow them to screen more samples in a
shorter amount of time.
Keywords: breast milk, breast milk banking, breastmilk sensor, polymer-based sensor,
microfluidics, multiplexed sensor, paper chromatography, E. coli detection
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CHAPTER 1: INTRODUCTION

1.1 Background Motivation and Big Picture Rationale
On a global scale, breast milk is considered the gold standard for infant nutrition.
Containing protective antibodies that optimize an infant’s chances of survival, breast milk is the
ideal substance to provide the necessary nourishment in the first six months of life.1 In addition
to offering essential nutrients, breastfeeding provides significant long-term benefits that can
contribute to positive health outcomes. It can lower the risk for infectious diseases like
diarrhea-related diseases and respiratory infections, as well as lowering the likelihood of
2

developing chronic conditions such as asthma and allergies in early childhood. Additionally, the
nutritive benefits of breast milk can be seen to enhance cognitive development, as demonstrated
when comparing intelligence quotients between children who were breastfed for seven months as
opposed to those who were only breastfed for one month.3 Lastly, breast milk provides
invaluable immune system benefits, which reportedly could prevent up to 13% of child deaths
worldwide.4
Although breastfeeding has been proven to be beneficial to infants and mothers alike,
many women are unable to breastfeed. One of the major reasons that can prohibit a mother from
breastfeeding her child is her own health status, as women who are infected with HIV/AIDS or
other chronic, blood-borne conditions are recommended not to breastfeed.5 Additionally, some
mothers do not breastfeed their infants because child may have a metabolic disorder whereby
they cannot digest breast milk or they are unable to latch on to the breast.6 Lastly, some mothers
do not breastfeed their children due to cultural factors. For instance, some mothers may work in
places that do not allow them to pump milk during the day, while others may not have adequate
support at home or not have anyone in their lives who has breastfed in the past.7 All of these
1

J. Wagner, C. Hanson, and A. Berry, “Donor Human Milk for Premature Infants: A Review of Current Evidence,” ICAN:
Infant, Child, & Adolescent Nutrition, vol. 5, no. 2, pp. 71-77, 2013.
2
“Breastfeeding and the Use of Human Milk,” American Academy of Pediatrics, vol. 129, no. 3, Mar. 2012.
3
M.S. Kramer, “Breastfeeding and Child Cognitive Development,” Archives of General Psychiatry, vol. 65, no. 5, pp. 578-584,
2008.
4
G. Jones, R.W. Steketee, R.E. Black, Z.A. Bhutta, S.S. Morris, , & Bellagio Child Survival Study Group, “How many child
deaths can we prevent this year?” The Lancet, vol. 362, pp.65-71, 2003.
5
“Acceptable medical reasons for use of breast milk substitutes,” World Health Organization, Geneva, Switzerland, 2009.
6
J.H. Kim and S. Unger, “Human milk banking,” Paediatrics Child Health, vol. 15, no. 9, pp. 595-598, Nov. 2010.
7
US Department of Health and Human Services. "The Surgeon General's call to action to support breastfeeding." 2011.
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factors can discourage mothers from breastfeeding their children, putting these infants at an
unfortunate disadvantage.

1.2 Breast Milk Banking Improves Access to Breast Milk for Infants in Need
In an attempt to increase access to human breast milk that is free from contamination
there has been a global emergence of human breast milk banks to help infants in need. Table 1
compares the number of milk banks, pasteurization method and quality control procedures of
human breast milk banks around the world.

Table 1. Comparison of Human Breast Milk Banks Globally

Country/Region

Number of Milk Banks

Pasteurization Method

Quality Control
Procedures

North America

26

Holder Method

Bacterial Culturing

Europe

214

Varies

Varies

Brazil

210

Holder Method

Dornic Acidity,
Bacterial Culturing,
Crematocrit Testing

South Africa

>12

Flash Pasteurization

Bacterial Culturing

India

14

Holder Method

Bacterial Culturing

Over the past several decades, North America has seen a growth in traditional human
breast milk banking, as indicated by the 26 human breast milk banks that are currently a part of
the Human Milk Banking Association of North America. In comparison with North America,
there are 214 human breast milk banks in Europe that are a part of the European Milk Bank
Association. France has the highest number of human breast milk banks with 36, whereas

12

countries like Russia and Portugal have 1 human breast milk bank each.8 However, as indicated
in Table 1, operating procedures vary amongst the EMBA members.
In considering countries in the developing world, Brazil has the most extensive and long
standing human breast milk banking system in the world. They have 210 breast milk banks
nationwide to support 3 million annual births. This extensive network has been a key factor in
decreasing the infant mortality rate by 73% from 1985 to 2013.9 In contrast to Brazil, South
Africa only has 12 breast milk banks. These breast milk banks face challenges of resource-poor
settings where they struggle with inadequate staffing and a lack the necessary funds for
equipment maintenance.10 Conversely, India is seeing substantial growth in the milk banking
industry. Although are only 14 human breast milk banks nationwide, which is not enough to
support over 25 million infants born annually, the Indian Academy of Pediatrics’ has made huge
strides in creating and updating a comprehensive set of guidelines for milk banks in India.11

1.2.1 Breast Milk Banking Process Overview

Figure 1. Schematic of operational flow for breast milk banking.

To verify the safety of donated human breast milk for consumption, human breast
milk banks have implemented controls to ensure there are no contaminants or dangerous
substances in the milk. The primary opportunities for contamination include the initial
lactation and pumping by the mother, initial storage, transportation to the milk bank,
reception at the milk bank, and operational operational processes within the bank itself.

8

“EMBA,” European Milk Bank Association, 2016.
F. Pires. (2014 Dec 2). Learning from Brazil’s success with milk banks. University of Michigan News.
10
I. Coutsoudis, M. Adhikari, N. Nair, and A. Coutsoudis, “Feasibility and safety of setting up a donor breastmilk bank in a
neonatal prem unit in a resource limited setting: An observational, longitudinal cohort study,” BMC Public Health, vol. 11, no.
356, 2011.
11
K. Bharadva et al., “Human milk banking guidelines,” Indian Pediatrics, vol. 51, no. 6, pp. 469-474, 2014.
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As such, a stringent quality control process must be implemented to ensure consumers are
not exposed to harmful contaminants.
Through a review of current best practices of safety controls employed by human
breast milk banks, the process outlined in Figure 1 was found to be the general breast
milk banking procedure to verify and ensure the safety of donated human breast milk.
The general milk banking process includes donor testing, breast milk donation,
pasteurization & screening tests, storage of the milk, and distribution to infants.12
The process begins with the human breast milk bank testing the donor’s blood
before she donates to ensure that the milk will not be able to transmit diseases such as
hepatitis B/C, syphilis or HIV/AIDS. Further the donor’s blood is tested to ensure that it
does not contain traces of illegal drugs, certain medications, tobacco products, herbal
supplements, or environmental contaminants as the presence of these substances in breast
milk can negatively impact a child’s health.13 Once a donor has been successfully
screened, she can donate human breast milk that may be collected at home or at the milk
bank.
Once the human breast milk has been donated, human milk banks will pasteurize
the collected milk to destroy any harmful bacteria present in it. Following pasteurization
the donated human breast milk is cultured, often times by a microbiological lab that is
external to the milk bank itself.
After the donated human breast milk has undergone pasteurization and culturing,
it should be stored at four degrees Celsius for up to 48 hours and frozen at negative 20
degrees Celsius for three to six months.14 Finally, the donated human breast milk is
distributed to mothers and infants in need.

1.2.2 Current Methods for Pasteurization at Milk Banks
The goal of pasteurization is to limit the risk of harmful bacteria present in
donated human breast milk. Pasteurization methods use high heat levels to inactivate
12

K. Bharadva et al.
K. Bharadva et al.
14
D. Silvestre, M.C. Löpez, L. March, A. Plaza, and C. Martinez-Costa. “Bactericidal activity of human milk: stability during
storage,” British Journal of Biomedical Science, vol. 63, no. 2, pp. 59-62, 2006.
13
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bacteria, viruses, and other potential pathogens.15 Although industrial-grade
pasteurizations are used in the dairy industry to ensure safety of dairy milk, many human
breast milk banks are unable to afford this type of technology because they can cost up to
$60,000.16 Instead, Holder pasteurization is a common method where donated human
breast milk is heated up to 62.5 degrees Celsius for 30 minutes in a shaker water bath.17
Another method called flash pasteurization involves heating the donated human breast
milk up to 72ºC for 16 seconds.18 These methods are widely practiced around the world at
human breast milk banks. Depending on the human breast milk bank, pooling of the
donated human breast milk from multiple donors may occur to maximize nutritional
content and uniformity.19 While pooling may overall enhance the quality of the donated
human breast milk, contamination makes it difficult to determine the source.20
Unfortunately, there is no guarantee pasteurization will destroy all of the harmful
bacteria present in the donated human breast milk. In addition, pasteurization may
negatively affect beneficial properties of the donated human breast milk. It generally does
not alter nutritional carbohydrate, fat, and salt composition, but the high level of heat may
reduce or destroy beneficial immune factors like IgA, IgG, IgM, and lactoferrin.21
However, without an alternative method, human breast milk banks continue to pasteurize
the donated breast milk to to ensure safety for infants.

1.2.3 Cost and Resource Efficiency of Culturing Method for Screening Breast Milk
Bacterial culturing may be done before and/or after to verify the success of
pasteurization in the human breast milk banking process. It is practiced pre-pasteurization
and post-pasteurization to determine the microbial content in donated human breast milk.
Pasteurization methods often do not maintain a high constant temperature resulting in

“Strengthening Human Milk Banking: A Global Implementation Framework,” PATH, 2013.
S. Landers, and K. Updegrove, “Bacteriological screening of donor human milk before and after Holder pasteurization,”
Breastfeeding Medicine, vol. 5, no. 3, pp. 117-121, 2010.
17
K. Bharadva et al.
18
W. E. Corpelejin, et al.
19
“Strengthening Human Milk Banking: A Global Implementation Framework,” PATH, 2013.
20
“Strengthening Human Milk Banking: A Global Implementation Framework,” PATH, 2013.
21
W. E. Corpelejin, et al.
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remaining bacterial contamination.22 Consequently, human breast milk banks send out
small samples or batches of donated human breast milk to a microbiological lab to
determine if any bacteria grows within a 24 hour period. Depending on the guidelines of
the human breast milk bank, if bacterial colony forming units (CFUs) are found above a
certain limit, the milk is likely discarded to ensure microbiological quality.23
Even though donated human breast milk could be heavily contaminated, bacterial
culturing is not standardized amongst human breast milk banks around the world. It is a
costly and lengthy process, so human breast milk banks must balance quality assurances
along with their own resources and financial limitations. Using a sterile laboratory and
hiring a highly trained laboratory technician quickly raise the costs for bacterial culturing.
Additionally, microbiological testing results are not instantaneous.
Measuring the full financial impact of human breast milk banks around the world
is a challenge. However, the processing and operating costs of donated human breast
milk appear to be negligible compared to the cost of treating vulnerable infants with
immune system diseases and complications.24 Bacterial culturing is important in
monitoring the success or failure of pasteurization methods to determine contamination
and prevent future problems for infants. Therefore, human breast milk banks may be a
more cost effective solution for infants and mothers in need.

1.3 Problem Statement
Current methods of culturing bacteria when testing samples is expensive and
time-consuming for milk banks in both developed and developing communities. To reduce these
factors, milk banks are in need of a rapid, affordable, accurate, and sensitive sensor that is able to
detect and quantify the presence and concentration of E. coli.

22
23
24

K. Bharadva et al.

K. Bharadva et al.
J.H. Kim, and S. Unger, “Human Milk Banking,” Paediatrics & Child Health, vol. 15, no. 9, pp. 595–598, 2010.
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1.4 Literature Review: Existing Diagnostics Technology for Human Breast Milk
The following table compares diagnostic technologies for breast milk and their varying
purposes, detection methods, prices, applications, and times required to obtain results. The
Happy Vitals test kit and the Milk Screen strips are commercially available, while the Biosensors
for Quality Assurance of Dairy Products, Food Biosensors, and Electrochemical DNA-based
biosensor, and Poly Methyl methacrylate (PMMA) “Lab-on-a-chip” for Human Breast Milk
Defatting are still in research stage.
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Table 2. Diagnostic products and technologies for milk on the market and under development.
Product

Component Detected

Detection Method

Price

Application Setting

Time

Happy Vitals25

Macronutrient levels,
heavy metals, vitamins,
minerals

Lab testing by
microbiologists

$169.95 $695.95

Commercially
available; lab screening
of samples sent from
mothers at home

3-5 days

Milk Screen by
Upstring Strips26

Alcohol,
Docosahexaenoic acid

Colorimetric test strip

$14.99 for
eight strips

Commercially
available; testing at
home

2 minutes

NeoGen Tests for
Dairy Products27

β-Lactoglobulin
(BLG), casein, total
milk (casein and whey
proteins), allergens,

Screening microwell tests,
test strips, lateral flow strips,
microwell enzyme-linked
immunosorbent assay
(ELISA) tests

Not
advertised

Commercially
available; used
throughout production
process

30 minutes

Soleris System and
Vials28

E. coli O157:H7

Ready-to-use vials with
colorimetric indicator,
incubator, and system
software

Not
advertised

Commercially
available; used
throughout production
process

4-24 hours

Biosensors for Quality
Assurance of Dairy
Products29

Nutrients and
pesticides

Temperature, light, bacteria

Variable,
>$1,000

Laboratory research,
primarily cow milk

Variable

Food Biosensors30

General quality,
carcinagen aflatoxin
M1

Optical biosensing of
chemiluminescence and
fluorescence detection

Variable,
>$1,000

Laboratory research,
primarily cow milk

Variable

Electrochemical
DNA-based biosensor

Bacillus cereus

DNA-based Au-nanoparticle
modified pencil graphite
electrode (PGE)

Low

Laboratory Research

Variable

Poly Methyl
methacrylate
(PMMA)
“Lab-on-a-chip”32

Energy content as
measured by fat,
protein and lactose

Cross-flow microfiltration
structure

Low

Laboratory research

Few
minutes-two
hours

31
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“Tracking Better Health for Mom and Baby.” Happy Vitals. N.p., n.d. Web. 20 November 2017.
“Milkscreen.” Milkscreen Home Test for Alcohol in Breast Milk. N.p., n.d. Web. 20 November 2017.
27
“Total Milk/Casin/BLG.” NeoGen. Happy Vitals. N.p., n.d. Web. 20 November 2017.
28
“E. coli Vial.” NeoGen. Happy Vitals. N.p., n.d. Web. 20 November 2017.
29
Pividori, Maria Isabel, Salvador Alegret. “Biosensors in Quality Assurance of Dairy Products.” Portable
Biosensing of Food Toxicants and Environmental Pollutants. Eds. Dimitrios P. Nikolelis, et al. CRC Press, 2013.
411-442.
30
Ahmed, M. U., Zourob, M., & Tamiya, E. Food biosensors. Cambridge: Royal Society of Chemistry, 2017. 521
pp.
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Izadi, Z., Sheikh-Zeinoddin, M., Ensafi, A. A., & Soleimanian-Zad, S. (2016). Fabrication of an electrochemical
DNA-based biosensor for Bacillus cereus detection in milk and infant formula. Biosensors & Bioelectronics,
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Lai, M., Lai, C. T., Keating, A., Dell, J., & Liu, Y. Cross-flow microfiltration for lab-on-chip defatting of human
breast milk. Biomedical Applications of Micro- and Nanoengineering IV and Complex Systems 2008. Doi:
10.1117/12.810584.
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1.5 Literature Review: Existing Low-Cost, Microfluidic Sensors for Bacterial Detection
1. Paper sensors for bacterial detection in dairy milk and orange juice33
Paper sensors exist in a simple kit that would allow for untrained personnel to carry out
sensitive, multiplexed detection E. coli in food samples. These paper based sensors utilize
sol-gel-derived silica inks placed by an ink-jet printing technique to produce colorimetric
results, which can be judged by the human eye or a combination of digital camera and
image analysis software.

2. Integrated capture, concentration, polymerase chain reaction, and capillary
electrophoretic analysis of pathogens on a chip34
This sensor is comprised of micropumps and valves on a PMMA chip that utilizes PCR
and amplicon separation for selective targeting of pathogens. As this sensor maintains
advantages such as analysis speed and compact size, it also boasts detection sensitivity
and analysis volume that are capable of identifying a dangerous pathogen with
contemporary significance at clinically relevant sensitivities (O157 E. coli at 0.2
CFU/µL).

3. Optical enzyme-linked immunosorbent assay on a strip for detection of Salmonella
typhimurium35
This rapid and sensitive enzyme-linked immunosorbent assay (ELISA) on an
immunochromatographic strip utilizes colorimetric and chemiluminescent techniques to
detect Salmonella typhimurium. It can quantitatively measure the pathogen in the range
of 9.2×103 to 9.2×106 CFU/mL within 20 min (colorimetric method) and 16 min
(chemiluminescent method).

33

Hossain, S. M., Ozimok, C., Sicard, C., Aguirre, S. D., Ali, M. M., Li, Y., & Brennan, J. D. Multiplexed paper test
strip for quantitative bacterial detection. Analytical and Bioanalytical Chemistry 2012, 403(6), 1567-1576.
doi:10.1007/s00216-012-5975-x
34
Beyor, Nathaniel et al. “Integrated Capture, Concentration, PCR, and Capillary Electrophoretic Analysis of
Pathogens on a Chip.” Analytical chemistry 81.9 (2009): 3523–3528. PMC. Web. 5 Dec. 2017.
35
Park, Sojung, Yong Tae Kim. “Optical Enzyme-linked Immunosorbent Assay on a Strip for Detection of
Salmonella typhimurium.” BioChip Journal 4.2 (2010): 110-16. Web.
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4. Microfluidic Assay for Continuous Bacteria Detection Using Antimicrobial Peptides
and Isotachophoresis36
This assay utilizes an electrophoretic focusing technique called isotachophoresis to
establish a channel of heavily concentrated antimicrobial peptides (AMPs). The
contaminated fluid travels down this channel and the bacteria is separated and from the
AMPs where its fluorescence signal to provide a detectable and quantifiable
measurement.

1.6 Field Review: Capturing Customer Desired Outcomes
1.6.1 Mothers’ Milk Bank of San Jose

Figure 2. Schematic of operational flow at Mother’s Milk Bank in San Jose, California.

A visit to Mother’s Milk Bank (MMB) in San Jose, California provided insight to
the industry and explained the bank’s processes.37
To begin, mothers who have passed the blood test screening pump their excess
milk into glass or plastic containers, package the containers in a cooler, and ship the
cooler to MMB. Upon reception of the shipments, MMB slowly thaws the milk breast
milk to keep the milks live tissue intact. Donations from about three donors are pooled
and stored in glass jars. The jars are then pasteurized at 62.5ºC for 30 minutes. After
pasteurization, a sample from each batch of pooled milk is cultured in a lab and a
microbiologist screens for colony-forming units. A significant portion of the donated
milk is thrown away due to contamination, but loss at MMB San Jose is about half the
rate at other milk banks in the United States. Clean milk is stored in -20ºC freezers
36

Schwartz, O., & Bercovici, M. (2014). Microfluidic Assay for Continuous Bacteria Detection Using Antimicrobial Peptides and
Isotachophoresis. American Chemical Society Publications,86. Retrieved December 5, 2017.
37
Sakamoto, Pauline. “Mother's Milk Bank Tour and Informational Interview.” 20 Oct. 2018.
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before being donated to infants in hospitals and homes, where it can be refrigerated for
24-48 hours.
The most common contaminant in donated human breast milk after pasteurization
is Bacillus cereus. MMB attributed this contamination to improper cleaning of the
mother’s pumps when they are expressing, but the proliferation of Bacillus cereus is
accelerated during pasteurization.
The demand for donated human breast milk from MMB surpasses the supply,
which is attributed to the promotion of human breast milk over formula by the private,
for-profit milk bank Prolacta. The existence of online milk banking—despite being illegal
in the state of California—evidences inadequate supply of donated breast milk and
mothers’ willingness to obtain it. Additionally, a lack of regulation prevents milk from
reaching infants high-risk who need it most. Rather, infants drinking milk obtained via
online avenues are 6 months old on average. In addition to feeding infants, human breast
milk is the only known treatment for necrotizing enterocolitis, a gangrene in the gut.
The existing standards place strict limits on the permissible contamination;
federal organization recommend that milk banks “kill all pathogens” in stored milk,
creating a zero tolerance for colony forming units. Elimination of these pathogens
through pasteurization, however, results in a loss of about 20% of the naturally occurring
immune factor IgA.
The criteria for a sensor to detect E. coli were outlined as follows:
● Objective results that eliminate the risk of human error in interpreting results,
preferable standard device that reads and displays quantifiable results
● Limit of detection 104 CFU/mL
● Prove that milk does not need to undergo pasteurization
1.6.2 PATH38
PATH is an international non-governmental organization (NGO) that leads global

38

PATH Informational Interview [Telephone interview]. (2017, December 4).
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health innovation by accelerating innovation across five different platforms: vaccines,
drugs, diagnostics, devices, and system and service innovations.39 Dr. Kiersten
Israel-Ballard and Kimberly Amundson provided insight to PATH’s mission, projects,
and resources they apply across the globe.
As a body working to improve health equity and innovating medical technology,
PATH provides expertise and tools to niche markets in order to break down barriers and
save lives. One of such markets include the Maternal Health sector.
As stated previously, there are no standards for storage and treatment of donated
human breast milk in human breast milk banks across the globe. While different
governance bodies have individual standards, human milk banks across the globe have
various practices to meet such standards. In an effort make improvement, PATH has
released national guidelines for human breast milk banks in India to “ensure timely
initiation of breastfeeding and promote breastfeeding practices.”40 By collecting feedback
from across the globe, PATH has created their Global Implementation Framework to
share information on best practices surrounding this sector.
Like Mother’s Milk Bank of San Jose, PATH described challenges surrounding
the human breast milk banking industry. They highlighted that many banks outsource
testing in order to determine if contamination is present within samples. This outsourcing
is both expensive and time-consuming, so professionals in underdeveloped settings often
do not have access to such resources and are in need of a simple, rapid, and point-of-care
solutions.
Lastly, PATH shed light on the implications that the sensor could potentially have
with breastfeeding mothers who may eventually see this product go to market. According
to feedback they collected, a common theme with mothers is that they never feel like they
are enough. Mothers feel like they could produce more milk with greater nutritional value
in order to provide the best care possible for their children. As a team working to develop

39

PATH: Driving Transformative Innovation to Save Lives. (n.d.). Retrieved December 5, 2017, from
https://www.path.org/index.php
40
Gurnani, V., Khera, A., Deb, S., Prabhakar, P. K., Singh, A., Kaujia, R., . . . Bhart, V. (n.d.). National Guidelines
on Lactation Management Centres in Public Health Facilities. Government of India: Child Health Division:
Ministry of Health and Family Welfare.
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a resource that could be perceived as a new tool to “judge” a mother’s milk, our team
must be cognizant of the ramifications that can result and its effects on mothers across the
globe.
1.6.3 Sion Hospital, Mumbai, India41
In June of 2017, one member of the 2016-17 senior design team, Callie Weber,
and one member of the EWH team, Karen Mac, toured the birthing unit, collection sites,
milk banking lab, and microbiology departments led by the PATH team at the Sion
Hospital in Mumbai, India. Here the team gained valuable insight for the future direction
of MilkGuard.
They learned that the sensor must guarantee results with 99% assurance in order
to be used in the milk bank setting. It must eliminate false positives, having the ability to
differentiate between the detection of E. coli and other pathogens. It must also eliminate
false negatives due to alternative cell lines of E. coli present in the sample.
The sensor must be able to detect other potential contaminants in breast milk in
order to be a viable alternative to bacterial culturing. Currently, Sion Hospital is mainly
concerned with the contaminants: Staphylococcus aureus, Asilobacterium, Klebsiella,
Enterobacterium, Enterococcus, and Bacillus, and gram-negative bacteria.
The strip’s colorimetric results should have a strict limit indicating the
permissible level of contaminant versus an unusable one. A quantification method
integrating a mobile phone application could potentially be employed, but the use of this
platform should take into consideration the willingness and aptitude of the hospital
employees to adopt its use. However, should it be used, then the solution should be
developed for Android given the predominance of Android users over iPhone users in
India. The hospital is currently making the transition from paper-based records to an
electronic medical record system, indicating the under resourced context in which the
strip could be used.

41

Weber, Callie, Mac, Karen. “MilkGuard: Mumbai Field Research Travel Report.” June 2017.
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The Sion Hospital Breast Milk Bank currently performs bacterial culturing before
and after pasteurization, but still pasteurizes all of their milk due to limited timing and
resources. A sensor with a limit of detection of 103 CFU/mL could stand in as a substitute
to culturing pre-pasteurization. This would allow for contaminated milk to be thrown out
without unnecessarily pasteurizing it. Additionally, the sensor would allow for milk to be
safely pooled into batches, which is the preferred method of most milk banks (including
Mother’s Milk Bank of San Jose) because it standardizes the nutritional content of the
donor milk for all recipients.

1.6.4 Mothers’ Milk Bank of Aurora
Mother’s Milk Bank of Aurora maintains all of the same HMBANA standards
and regulations as Mother’s Milk of San Jose. Rather than screening their milk on-site,
this bank outsources the bacterial culturing tests to a laboratory, which can take up to
three days for transportation, testing, and results. Given the bank’s holistic approach to
maternal health, they brought to attention the psychological impact which a product that
qualifies the viability of a mother’s breast milk could have on a mother who is already in
a compromised or sensitive state.

1.6.5 Northwest Mothers Milk Bank of Portland
Northwest Mothers Milk Bank adheres to the standards set by HMBANA. This
bank also outsources their bacterial culturing tests to a laboratory, taking up to three days
for transportation, testing, and results. The bacterial tests are unspecific. Although this
bank also follows a “zero tolerance” policy for bacterial contamination, they retest any
results that come back between 10 and 50 CFU/mL. Sometimes the milk resulting in 10
to 20 CFU/mL contamination can successfully pass a retest and be cleared for
distribution. The milk between 20 and 50 CFU/mL usually fails a retest. This bank only
performs post-pasteurization tests. They cannot justify paying for pre-pasteurization tests
due to the high percentage of milk that passes the tests after pasteurization. However,
they did recognize that a fairly cheap method for pre-pasteurization screening, such as
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our device, would be useful in eliminating the pasteurization process for milk that is
highly contaminated. This milk would instead be thrown away initially, instead of
undergoing the pasteurization process, waiting for test results, then throwing it away.

1.7 Project Goal
The overall goal of the project is to develop a low-cost, polymer-based sensor that detects
Escherichia coli bacteria in donated human breast milk. The sensor aims to enable easy, efficient
detection, eliminating the need for pasteurization of uncontaminated donated human breast milk
in breast milk banks.

1.8 Project Objectives
The sensor’s development is focused on time and cost factors that are associated with the
pasteurization and culturing of cells within donated human breast milk at established breast
banks. Based upon customer interviews with Mother’s Milk Bank of San Jose, PATH, and other
milk banks associated with the Human Milk Banking Association of North America, criteria
include, but are not limited to:
● Sensing contamination of at least 103 CFU/mL
● Obtain objective, precise, and quantifiable results
● Mitigation of false positives and false negatives

Our overall goal is to create a simple, affordable, and easily manufacturable sensor that
can consistently test for a variety of pathogens found within donated human breast milk in both
underdeveloped and developed industry settings. To do so, we plan on taking the following
steps:
● Replicate detection method of ß-galactosidase in breast milk
● Ensure detection method of ß-galactosidase is compatible in breast milk
● Determine sensor sensitivity
● Improve uniformity of biological reagent deposition on sensor
● Accelerate cell-lysing steps
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1.9 Solution Ideation
1.9.1 Existing Sensor Mechanism Overview
The proposed method of using the paper based sensor consists of the following steps:
1. E. coli cells in human breast milk sample will be lysed prior to use of paper based
sensor.
2. The bottom part of the sensor will be dipped into the milk sample.
3. The enzymes from the E. coli cells will hydrolyze the substrate on the sensor,
causing a blue color to form in the presence of contamination greater than 103
CFU/mL.
4. Calorimetric results will be read by user to determine safety for consumption.

1.9.2 Opportunities for Improvement Upon MilkGuard Sensor
1. Lower limit of detection to 103 CFU/mL
Since trace amounts of bacteria are capable of compromising an infant’s growing
immune system, the sensor must be able to detect low concentrations to ensure infant
health safety.
2. Develop a multiplexed sensor to test for additional contaminants
The MilkGuard sensor could be adapted to test for additional pathogens that are of
primary concern in the storage of breast milk. The sensor could have the ability to test
multiple pathogens simultaneously.
3. Improve dispensing techniques
Create an easy method for users to deposit milk on the strip.
4. Improve manufacturability
Implement the use of gel-printing to rapidly create more uniform test strips.
5. Optimize packaging
Design a package that will provide satisfactory storage, enabling the sensor to have a
long shelf life and still be easy to open.
6. Develop mobile image capture for quantification of bacterial contamination
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A mobile phone application that could provide real time quantification of
contamination would greatly benefit the end user. As android phones are becoming
more popular, a mobile platform would allow greater access to powerful data
analysis.

1.9.3 Anticipated Modifications to Mechanism
1. ß-galactosidase v. ß-glucuronidase. The current prototype senses the presence of E.
coli via the presence of ß-glucuronidase, however, sensor’s specifications could be
improved by changing the detection method to sense ß-galactosidase. The detection
of ß-galactosidase is a known and effective standard method of detection for many E.
coli strains.42 In collaboration with a microbiologist, Dr. Craig Stephens, PhD,
changing the enzyme detected could improve the sensor’s functionality as lactose,
present in both dairy and human breast milk, catalyzes the production of
ß-galactosidase in strains with an intact LacZ gene.43 This alteration has potential to
improve the functionality of the sensor as it is used in a breast milk buffer.
2. Uniform Printing. The reagents could be deposited onto the paper surface via ink-jet
printing. This structured-layers approach prints a capture layer (polyvinyl amine), a
lower sol–gel-derived silica layer, the reagent, and a top silica layer, with reagents
entrapped in corresponding zones.44 To optimize the printing performance (ability to
jet the inks) as well as the enzyme activity, the different printing solutions could be
modified by the addition of glycerol, to control viscosity, and Triton X-100, to control
surface tension.45 The piezoelectric Epson Stylus C88 Inkjet Printer will be used to

Rivas, L., Mellor, G. E., Gobius, K., & Fegan, N. (2015). Detection and typing strategies for pathogenic
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45
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Pelton, Carlos D. M. Filipe, and John D. Brennan. Development of a Bioactive Paper Sensor for Detection of
Neurotoxins Using Piezoelectric Inkjet Printing of Sol−Gel-Derived Bioinks. Analytical Chemistry 2009 81 (13),
5474-5483 DOI: 10.1021/ac900660p
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deposit the layers and manufacture sensors on Whatman Grade 1 Qualitative Filter
Paper, improving the sensor’s deposition uniformity and economy of scale.
3. Immunomagnetic Separation. IMS would allow the sensor to selectively detect a
target pathogen. It allows a target organism to be separated from a food matrix and
background microflora, and concentrated into a smaller sample volume, which would
make it easier for a paper strip to detect a concentrated E. coli sample.46
The sensor’s efficiency will be improved by streamlining time-consuming,
pre-treatment steps onto the sensor. Its applicability will be enhanced by lowering the
sensor’s limit of detection, and its reliability will be guaranteed through the mitigation of
false negatives and false positives. Finally, its viability as a consumer product will be
enabled through manufacturable, scalable preparation.

1.10 Key Deliverables
The key deliverables of the project are the following:
1. Produce consistent prototype sensor.
2. Verify the viability of ß-galactosidase detection in human breast milk.
3. Generate standard concentration curve corresponding to colorimetric results for
ß-galactosidase detection.
The expected results are the following:
1. Prepare the sensor for production using IMS for cell-lysing and an inkjet printer for
uniform deposition of gel on paper sensor.
2. Continue partnerships with key nonprofits to ensure sensor can be field tested with real
impact.

46
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1.11 Team and Project Management
The team has been communicable, organized, and proactive with the goals and progress
of the project each week, quarter, and over the course of the year. Effective communication and
record keeping prevent misunderstandings and allow for discussion in the case of disagreements.
Each teammate’s dedication enables discovery to be made, and the team’s understanding of how
each teammate can contribute given their strengths, schedule, and demands at a given point in
time allows for dynamic collaboration and delegation.
The team agreed upon a Team Charter at the beginning of the project. The Charter
outlined objectives, responsibilities, consequences, milestones, and expectations for the duration
of the project. The agreement ensured that all team members were on the same page regarding
what was expected of them and prevented conflict from arising.
Through collaboration Engineering World Health and the School of Engineering, two
faculty advisors on the project contributed their expertise. Dr. Parker from the Public Health
Department and Dr. Kim from the Bioengineering Department served as these advisors. The
bioengineers met with Dr. Kim weekly to discuss experiment results, propose goals for the
following week, and talk through concepts. They also met with Dr. Parker periodically to discuss
the future of the project and potential opportunities for advancing the project. The EWH students
attended a class with Dr. Parker each week as well as a weekly meeting with the bioengineering
students to share ideas.
Weekly meetings were a platform to share findings in the lab, explain conceptual design
components, brainstorm ideas, hypothesize outcomes, and outline action items. The action items
allowed team members to assign tasks, report progress, and hold one another accountable for
deadlines.
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Table 3: Team Member Roles and Responsibility
Team Member

Role

Nick Kikuchi
Bioengineering

● Correspondent with Dr. Mobed-Miremadi
● Lead in gel entrapment procedures
● Maintains experiment log

Maggie May
Bioengineering

● Correspondent with Mother’s Milk Bank and Dr. Barber
● Thesis organization and documentation
● Runs assays alongside Nick and Matt

Matt Zweber
Bioengineering

● Correspondent with Dr. Stephens
● Orders materials and manages inventory
● Organizes results of collected data

Sara Kelly
Public Health

● Assists in background research
● Prepares content for conference applications

Karen Mac
Public Health

● Mumbai Trip Researcher
● Prepares content for conference applications

Maya Tromburg
Public Health

● Assists in background research
● Prepares content for conference applications

Dr. Unyoung Kim
Bioengineering
(Advisor)

● Medical device advisor provides insight into experimental
design
● Guides team in experiment design and data organization

Dr. Michele Parker
Public Health
(Advisor)

● Advisor provides feedback regarding design application
● Edits conference applications and advises team on future work

Dr. Maryam
Mobed-Miremadi
Bioengineering
(Advisor)

● Biomolecular advisor provides insight into experimental design
● Guides team in experiment design and data organization

1.12 Budget
Our budget mainly consisted of lab supplies. We anticipated buying most of the items
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that we did end up purchasing. These items were reasonably priced within our budget. The only
surprise was purchasing $800 worth of breast milk, which happened over a slight
miscommunication. Fortunately, we were able to pay for the breast milk and continue to
purchase other necessary materials.

1.13 Timeline
The progress made on the development of the sensor was limited by the nine month time
period allotted for work. The need research and establishing familiarity with previous laboratory
protocols took place from September-December 2017. A majority of the laboratory work took
place from January-June 2018.

CHAPTER 2: SOLUTION OVERVIEW AND DESIGN RATIONALE
2.1 Overview of Sensor Design and Application
The sensor relies on the indirect detection of E. coli through the binding of the enzyme
ß-galactosidase with the substrate X-gal. ß-galactosidase is expressed by E. coli, and as a
reporter gene expressed in the lacZ operon, its presence therefore indicates the presence of E.
coli. Upon X-gal hydrolysis of ß-galactosidase, galactose and 5-bromo-4-chloro-3-hydroxyindole
is yielded. The 5-bromo-4-chloro-3-hydroxyindole then spontaneously dimerizes and is oxidized
into 5,5'-dibromo-4,4'-dichloro-indigo, an intensely blue, insoluble product. In order to obtain
this blue product, the milk sample must be prepared with E. coli and lysed. The sensor must
entrap X-gal within a platform upon which the milk sample can be deposited so that the reaction
can take place for colorimetric analysis.
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Figure 3. Sensor Schematic and Application. The ß-galactosidase, expressed by E. coli, resides within the milk
sample. A drop from the milk sample is deposited onto the central sensor, which contains the substrate X-gal. The
color change produced within the sensor can then be compared to the key, which indicates the concentration of
bacteria contamination corresponding to the observed color change.

2.2 Key Constraints: Customer Needs and System-Level Requirements
The sensor is designed to meet the needs of breast milk banks around the world,
particularly those in developing countries. The World Health Organization outlines the
ASSURED criteria for point-of-care devices: affordable, sensitive, specific, user-friendly, rapid
and robust, equipment-free and deliverable to end-users. Thus, criteria were adopted from these
recommendations for the design of the sensor:
Affordable: The device must cost less than $1.00 to ensure accessibility for low-resource
settings.
Sensitive: The device must have a low limit of detection (preferably 103 CFU/mL).
Specific: The device must consistently detect certain bacteria. Ideally, it must guarantee
that it is not detecting interference from a non-targeted bacteria.
Minimal pretreatment of sample: The device must be user friendly and not require
additional equipment.
Quantified, Objective Results: The sensor must clearly indicate the presence or absence
of bacteria.
Rapid: The device must provide results in under 24 hours.
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Frugal: The device must be easy to dispose and portable.
2.3 Detailed Design Description
2.3.1 Indirect Biomolecular Detection Method
ß-galactosidase is induced in E. coli cells by the lactose in human breast milk.
Based off of this induction, X-gal is allowed to react with ß-gal. The color produced from
X-gal hydrolysing ß-gal represents the indirect result of the concentration of E. coli cells
in a sample.

2.3.2 Lysing Step
The lysing step prepares the cells such that the enzymes β-glucuronidase and
β-galactosidase can access the substrate X-glucuronidase and X-galactosidase,
respectively. Some methods permeabilize the cell membrane rather than break it down
entirely.

2.3.3 Gel Entrapment
Gel entrapment is a key component to our sensors construction that allows for
substrates to retain their bioactivity and functionality because they are able to sustain
their native-state conformations.47 Our team used this method to entrap our substrate
(X-gal) to retain its activity and replicate our assay on the polymer-based platform.
2.3.3.1 Alginate Gel. Alginate is a naturally-occurring, water-soluble polymer that is
composed of (1,4)-linked β-D-mannuronic and (1,3)-α-L-guluronic acid residues. As an
organic copolymer, it is a cheap and thoroughly researched biomaterial that has multiple
applications in microencapsulation of numerous substrates.48 Alginate was chosen as a
47
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Maryam Mobed-Miremadi. “Cross-Linked Alginate Film Pore Size Determination Using Atomic Force Microscopy
and Validation Using Diffusivity Determinations.” Journal of Surface Engineered Materials and Advanced
Technology. 3 (2013): 1-12.
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method of entrapment and immobilization of biomolecules for a polymer-based platform.
Due to its inertness, alginate gels allow biomolecules to retain their bioactivity without
affecting the physical or chemical structures.49
2.3.3.2 Rationale for Alginate Gel Compared to Other Entrapment Gels. Alginate gel
was chosen as an entrapment technique over other methods including bioaffinity
attachment, covalent bonding techniques, and silica sol-gel immobilization due to ease of
fabrication, cost, and uniformity of its mesh and pore size. While the previous team used
silica-sol gels as their entrapment mechanism, research proved that alginate acted as a
more effective option.
Bioaffinity attachment relies on cellulose binding domains (CBD) that tags and
fuses the desired protein to the paper-based platform.50 Covalent chemical bonding
immobilization relies on the presence of biomolecules and functional groups to create
rapid immobilization on the paper platform through covalent bonds.51 Silica sol-gels can
be created from a number of precursors including Si(OEt)4 (TEOS), Si(OMe)4 (TMOS),
or sodium silicate. No matter the method of production, a sol-gel is created that is able to
entrap biomolecules without interfering with that substrate’s bioactivity.52 Though all
methods are effective for immobilization of biomolecules on paper-based platforms,
alginate is superior due to its ease of manufacturability, cost, and uniformity.
2.3.3.3 Comparison of Gel Entrapment Methods. Previously, the sensor’s design
utilized silica sol-gels for the entrapment of biomolecules on a paper-based format. Our
team explored the use of alginate gels due to its ease of manufacturability, cost, and
uniformity.

Table 4. Comparison of key characteristics between silica sol-gel and alginate.
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Characteristic

Alginate

Silica Sol-Gel

Gel Fabrication

Simple

Medium

Cost

Low

Low

Uniformity Control

Automatic Mesh Uniformity

Controllable Pore Size
Uniformity

Sensor Fabrication

Low

Medium

Complexity

In comparison between the use of alginate and silica sol-gels, four factors were
considered: gel fabrication, cost, uniformity control, and sensor fabrication.
Manufacturability. Both gels are easily fabricated. They both only require
simple steps in order to create the gel solution (refer to Materials and Methods).
However, silica sol-gels require the use of a vacuum filtration system and syringe filters.
Silica sol-gels also require the addition of glycerol in order to adjust viscosity and surface
tension that affected the gelation of the sol-gel. Alginate simply requires a cross-linking
solution and drying times in order to create the gel-like structure.
Cost. Silica sol-gel is very cheap, however alginate is significantly cheaper,
therefore alginate proves to be a more economically viable option.
Uniformity Control. The gels’ pore size are the key component that allow for the
correct function of the gels on the sensor. The pores allow for the desired enzyme to
travel through the pore and react with the biomolecules (substrates) that retain bioactivity
while entrapped in the gel. Depending on deposition methods and production method, the
pore size is variable. Originally, the silica sol-gels were pipetted directly into a mold to
create the gel layers on the sensor. However, doing so relies heavily on human production
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which often results in human errors and non-uniform deposition of the layer. This creates
variable pore sizes. To fix such issue, we attempted use of printers to improve uniformity.
Table 5 compares two printing methods.
Table 5. Comparison of Hp Volumetric Dispenser vs. Inkjet Printing Methods

Printer

Advantages

Disadvantages

Hp Volumetric

● Allows for small volume

● Requires the addition of surfactant to

Dispenser

deposition

reduce surface tension.

● Uniform layers

● Limits glycerol addition to 0% - 20%

● Rapid deposition

● Limits the amount of sodium silicate
present in the gel

Inkjet Printer

● Uniform layers

● Requires compatible viscosity with

● Rapid deposition

ink cartridge
● High potential to clog ink cartridge

Though both methods of printing simplify manufacturability of such layers, they also
pose additional complications. To meet the requirements of each printers, changes to the
viscosity and surface tension of the gels must be variable. The biggest problem is
balancing the composition of the gel with the parameters of the printers. The use of
alginate allows for a simplified fabrication process of gels. Instead of needing to use a
printer or chemical reactions to control and create uniform pore sizes, alginate
automatically creates a uniform mesh. No matter the method of fabrication of such gel
(refer to Materials and Methods), the addition of cross-linking solution forces
individual alginate strands to arrange in a uniform mesh with non-variable pore sizes.
Sensor Fabrication. When utilizing silica sol-gel layers, the sensor requires the
presence of three separate regions (refer to Sensor Design). The first two layers are
present to encapsulate ferric chloride and X-gus. The third layer acts as a hydrophobic
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barrier to stop the blue color indication from progressing further down the paper. The
adaptation of alginate on the sensor simplifies its manufacturability even more. Ferric
chloride acts as a trivalent cross-linker for alginate and according to our research, does
not necessarily catalyze the reaction between X-gal and ß-galactosidase. So, we can
eliminate this region as it is not beneficial to the sensor’s functionality as it was
previously when our method of indication relied upon the reaction between X-gus and
ß-glucuronidase. In addition, the sensor’s alginate layer is created by using 3% alginate in
order to create a pore size of approximately 3 nm. The alginate is mixed directly with the
X-gal, so the cross-linked strands contain the X-gal within its structure, which eliminates
the need to “entrap” the substrate between two distinct layers. Due to this fabrication
method, we are able to deposit the sample directly onto the gel and, due to its
predetermined pore size, enable the substrate to diffuse out of the gel to meet with the
ß-galactosidase. The determined volume of sample mixed with the gel eliminates the
need for the MSQ layer present in the initial sensor design.

2.3.4 Sensor Design
2.3.4.1 Revised Design. After determining that a lateral flow method was not suitable for
our sensor as it would allow for the possibility of contaminant entrapment within the
paper pores, our design switched to a drop-based format. Here, a user would simply need
to deposit a specific volume directly onto the sensor and allow the reaction to take place
over the necessary period of time.
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Figure 4. MilkGuard Revised Design. The sensor has a circular shape with an attached legend or key in the outer
concentric circle to to allow for direct sample comparison. The alginate-based sample is located in the inner
concentric circle where the reaction and blue color change will take place.

2.4 Expected Results
The sensor will produce a blue color change in the presence of E. coli, and a colorimetric
spectrum corresponding to E. coli  concentrations will be developed.
2.5 A Backup Plan
In the case that the alginate capsules and slabs do not prove to be valid methods for X-gal
entrapment and desired colorimetric indicators, the silica sol-gel method can be further explored
and optimized. The HP Volumetric dispenser can be used to print the PVAm and XG layers,
while the EPSON inkjet printer can be used to print the silica sol-gel layers.
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CHAPTER 3: MATERIALS AND METHODS
3.1 Materials
Pasteurized human breast milk was purchased from Mother’s Milk Bank (San Jose, CA)
to test the efficacy of the detection method in solution and in alginate. SCU-104 Escherichia coli
cells used to contaminate the human breast milk samples were given to us by Dr. Craig Stephens
of the Santa Clara University Biology Department. The cells were grown in LB broth from
Sigma Aldrich, Inc. (St. Louis, MI). The cells were lysed with Thermo Fisher’s B-PER Direct
Bacterial Protein Extraction Kit, Lysozyme, and DNAse (Waltham, MA) or permeabilized with
chloroform and sodium dodecyl sulfate (SDS) given to us by the Bioengineering Department of
Santa Clara University (Santa Clara, CA). X-gal (5-Bromo-4-Chloro-3-Indolyl
β-D-Galactopyranoside) from Thermo Fisher was used as the substrate in the enzyme-substrate
reaction and dissolved in N,N-Dimethylformamide from Sigma Aldrich, Inc. The Bioengineering
Department of Santa Clara University provided us with materials to make alginate capsules:
alginate powder, 1.5% CaCl solution, 0.9% NaCl solution, 1 mL syringe, 18G 1 ½ inch precision
needle, and a cell strainer.

3.2 Methods
3.2.1 Growth of E. coli Cells
A swab of SCU-104 E. coli cells was placed into 2 mL of LB broth in a 10 mL
tube. In early experiments, IPTG was mixed into the LB/cell mixture to induce the lacZ
gene in the E. coli cells. However, IPTG was replaced with human breast milk for the
majority of experiments. Once mixed, the 10 mL tube was placed into an incubator at
37˚C and shaken at 225 rpm for approximately 10 hours. This time period allows the cells
to surpass the log phase into their fully matured phase. Once incubated, the cells were
removed and measured in a spectrophotometer. Absorbance measurements were taken at
OD 600 to determine the concentration of E. coli in the sample in CFU/mL.
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3.2.2 Dilution Preparation
Dilutions are prepared to create a set of contaminated samples of donated human
breast milk with known concentrations. Initially, dilutions were prepared concentrations
ranging from 104 - 108 CFU/mL in order to ensure detection of higher concentrations of
ß-galactosidase. Once our protocol had been validated at these higher concentrations and
we obtained consistent detection, we expanded this range to create dilutions ranging from
102 - 108 CFU/mL in an attempt to increase the sensor sensitivity.

3.2.3 Lysing Step
The E. coli cells are lysed in order to allow the ß-galactosidase protein to escape
the cell membrane. To prepare each concentration of the serial dilution for completion of
the Miller or B-PER protocols, the solutions are first centrifuged at 3000 g for 5 minutes.
The supernatant is then extracted from each tube via pipet, and 400 µL of 50mM
NaH2PO4 are added to each tube to resuspend the cell. Either B-PER solution or
chloroform and SDS (sodium dodecyl sulfate) are added to each tube to lyse or
permeabilize the cells. The cell solutions are then shaken at 225 rpm for 15 minutes.
Once the cell membrane is lysed or permeabilized, the ß-galactosidase is able to react
freely with the X-gal to produce a blue color.

3.2.2.1 B-PER Protocol. To lyse the cell membrane, 100 mL of B-PER solution is added
to each concentration of E. coli solution in the serial dilution. The solution is made of
~0.8% lysozyme, ~0.8% DNAase, and 98.4% B-PER by volume. The solutions are then
incubated in a shaker for 15 minutes before adding X-gal.

3.2.3 Preparation and Construction of Alginate Gel Sensor
Using alginate as an entrapment mechanism allows for the simplification of the
sensor design. With several comparably simple preparation methods, substrates can be
easily entrapped within this gel and retain their bioactivity. This allows for our sensor to
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contain one, all-inclusive layer that not only contains a bioactive substrate, but also
contains the blue color change within a defined boundary.
3.2.3.1 Alginate Mixing Preparation. Our group utilized a 3% alginate mixture because
we wanted to obtain the structure and viscosity of 2% alginate mixture when
cross-linking. Because the alginate is autoclaved to eliminate possibilities of
contamination, the extreme heat causes the 3% mixture to shrink to the structure and size
of a 2% mixture. To prepare the 3% alginate gel, 3 g of Alginic acid sodium salt from
brown algae was mixed with 100 mL of 0.9% NaCl. This mixture was spun for 24 hours
at 650 rpm using a magnetic stir bar and corresponding spinner. The mixture was
checked periodically during the 24 hours, and in the case of clumping, large pieces were
broken apart to increase uniformity. After the alginate solution is prepared, it was then
autoclaved to eliminate chances for contamination. Once completed, 19 mL of alginate
was mixed with 1 mL of X-gal stock solution (created by mixing 20 mg in 1 mL of
dimethylformamide) for 4 hours. This ratio of alginate to X-gal was chosen to previously
obtain a 1:1 ratio of alginate to X-gal to produce uniform results within the alginate gels.
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After optimization, this 1:1 ratio was determined to be non-ideal for our protocol.

Therefore, the concentration of X-gal in the alginate was increased.
3.2.4.2 Alginate Capsule Preparation. Alginate capsules were prepared by using 1 mL
of alginate mixed with X-gal. To create the slabs, a 1 mL syringe and an 18 gauge, 1.5 in.
long needle were used. Using constant and steady pressure application, small and uniform
capsules were deposited directly into the 1.5% CaCl2 cross-linking solution. This method
of capsules preparation was used to allow for higher optical observations as our team
optimized our sensor’s functionality. After cross-linking for 30 minutes, the capsules
were removed from the solution and filtered using a cell strainer. The capsules were
washed three times with 0.9% NaCl to stop all cross-linking activity.54
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3.2.5 Monitoring Biomolecular Activity on the Sensor
Biomolecular activity on the sensor is monitored every hour by one of three
senior design team members. The intensity of the blue color is observed by the human
eye, and results are recorded by subjective words describing characteristics such as color,
turbidity, or separation of layers.
During optimization and confirmation experiments (See 4.22 and 4.23), the
intensity of the blue color was observed by the human eye referencing the following scale
derived by assigning arbitrary values to the range of blue intensities produced in the
experiment. Blue intensity was observed at hourly or bi-hourly time intervals before the
optimum time for observation and data collection was determined.

Figure 4. Original used to assign arbitrary values to blue color on the sensor. This scale was originally used to
attempt to quantify blue color change results. This allowed for the normalization of results before our group was
able to create an accurate and precise scale according to the actual obtained color change.

and Validation Using Diffusivity Determinations.” Journal of Surface Engineered Materials and Advanced
Technology. 3 (2013): 1-12.
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3.2.6 Measurement of Biomolecular Activity on the Sensor
After 8 hours, when the optimum blue color change was observed, a picture of
sensor was taken using an iPhone camera. The image was uploaded to ImageJ, an open
source image processing program developed at the National Institutes of Health. As seen
in Figure 5, mean intensity values of each well in the images were extracted and
imported into Excel. The intensity values were normalized to the control wells, and
standard curves were generated.
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Figure 5. ImageJ tool, analysis methods, and results. Each well-plate was sampled using the
ImageJ tool to allow for the standard curve generation of the mean intensity values.
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CHAPTER 4: RESULTS AND DISCUSSION
4.1 Determination of Optimal E. coli Strain and Enzyme Combination
4.1.1 Experiment
ß-glucuronidase and ß-galactosidase were compared as optimal enzymes to detect
in BL21 E. coli in order to produce the most intense blue color. The E. coli was grown in
2 mL of LB broth and 200 µL of IPTG, a molecular mimic of allolactose, in order to
induce the ß-galactosidase. Two serial dilutions were prepared using phosphate buffer to
obtain concentrations of E. coli ranging from 3.16 x 108 to 104 CFU/mL. Both dilutions
were lysed using the B-PER protocol. One dilution used the substrate X-gus to react with
ß-glucuronidase, and the other dilution used the substrate X-gal to react with
ß-galactosidase. Lower limits of detection were determined by observing any trace of
blue color in each centrifuge by eye.
Another experiment was performed to determine if a natural strain of E. coli
would best fit the model of our desired final product. The cells were grown with 200 µL
of pasteurized human breast milk (HBM), replacing IPTG, in order to induce production
of ß-galactosidase. Three serial dilutions were prepared using HBM as the buffer. The
naturally occuring strain “SCU-104” was inoculated into one dilution ranging from 3.16
x 108 to 103 CFU/mL. BL21 E. coli was inoculated into two dilutions ranging from 2.26 x
108 to 103 CFU/mL. All dilutions were lysed using the B-PER protocol. The SCU-104
dilution used X-gal, while the BL21 dilutions used X-gal for one and X-gus for the other.
Binary existence of blue color was determined by eye in each centrifuge tube.

4.1.2 Results
In the experiment comparing ß-glucuronidase to ß-galactosidase, the
X-gal/ß-galactosidase detection method proved to be more sensitive at a 1.00 x 107
CFU/mL lower limit of detection after 10 hours, whereas the X-gus/ß-glucuronidase
yielded a lower limit of 3.16 x 108 CFU/mL in the same period of time.
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In the experiment comparing the two E. coli strains, SCU-104 and BL21, no color
was observed in the BL21 dilution using X-gus after 10 hours. For BL21 using X-gal, a
1.00 x 106 CFU/mL lower limit of detection was observed after 10 hours. For SCU-104
using X-gal, a 3.16 x 106 CFU/mL lower limit of detection was observed after 10 hours.

4.1.3 Discussion
ß-galactosidase was determined to be a more sensitive method of detection than
ß-glucuronidase. We decided to continue our experiments using ß-galactosidase and
X-gal for the enzyme-substrate reaction. Although the limit of detection for BL21 was
slightly lower than that of SCU-104, we decided to use the SCU-104 strain going
forward, as the naturally occuring strain better represents E. coli that our device would
encounter in the real world. The blue intensity for each concentration of E. coli was also
more intense in the SCU-104 strain.
4.2 Viability of Alginate Gel Entrapment
4.2.1 Experiment
Alginate was prepared in a ratio of 1 mg X-gal:1 mL alginate. 1 mL of alginate
was dispensed from a syringe onto a glass slide. The alginate was cross linked with 1.5%
CaCl for 1 hour. Cross linking was stopped with 0.9% NaCl. The alginate was cut into 9
approximately equal sizes; each piece was placed in a 12 well plate to await dispensing of
lysate. A serial dilution of SCU-104 E. coli was prepared in HBM with ranges of 3.16 x
108 to 104 CFU/mL. The dilution was lysed with the B-PER protocol. Lysate was
dispensed in 20 µL volumes onto each piece of alginate in the 12 well plate. The time
between the end of cross linking and the dispensing of lysate was 10 minutes. Color was
observed by eye in hour increments throughout the day.

4.2.2 Results
The first noticeable color change appeared in the top concentration, 3.16 x 108
CFU/mL, at 4 hours. At 48 hours, color was observed down to 105 CFU/mL.
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4.2.3 Discussion
This experiment simply determined that we can observe color change in alginate.
From here we decided to further explore the possibility of alginate as a medium for our
enzyme-substrate reaction.

4.3 Effect of Substrate Concentration in Alginate Entrapment
4.3.1 Experiment
A serial dilution was created to obtain concentrations ranging from
3.16 x 108 to 104 CFU/mL. Two separate dilutions were created identical and were tested
on alginate slabs with different ratios of substrate concentrations entrapped within its
matrix. One dilution was lysed with the B-PER Protein Extraction Reagent Kit and an
identical dilution was lysed with the standard Miller Permeabilization. Alginate slabs
were created in two different ratios: 1:1 X-gal substrate/1 mL of alginate and 2:1 X-gal
substrate/1 mL of alginate. The prepared slabs were each cut into two rows of eight
segments. All thirty-two slabs were placed within a 48-well plate and received assay
samples that underwent both lysis procedures.

4.3.2 Results
The Miller Permeabilization protocol consistently produced faster results
compared to the B-PER protocol. For both lysis methods, the 2:1 substrate/alginate
mixture originally produced a darker color change, however, over time, the difference
between the 1:1 and 2:1 substrate/alginate mixture experienced color change became
negligible.

4.3.3 Discussion
Because both ratios of substrate to alginate produced similar color change after
the same amount of time, for simplicity, future experiments were conducted using a 1:1
substrate/alginate mixture. Our team deemed that there was no significant difference
when using such ratios.
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4.4 Evaluation of Uniformity of Color Diffusion in Alginate
4.4.1 Experiment
Samples of milk were inoculated with 3.16 x 108 CFU/mL, lysed with two
different lysis protocols, and deposited on alginate (1 mg X-gal/1mL alginate) slabs to
test for uniformity of the color diffusion throughout the gel upon and after reaction. The
prepared slabs were cut into two rows of eight segments. The top eight segments were
placed in individual wells in a 48-well plate and received assay samples that underwent
Miller permeabilization; the bottom six segments were also placed in individual wells in
a 48-well plate, but received assay samples that underwent B-PER lysis.

4.4.2 Results
More intense and uniform color change was observed on slabs which had been
covered in assay that underwent Miller permeabilization than those that had been covered
in assay that had been lysed using B-PER. Overall, the segments varied in uniformity and
diffusion of blue color, and much of the blue color collected on the edges or corners of
the slab segments.

4.4.3 Discussion
Because uneven and irregular distribution of blue color change remained an issue,
the capsule method was explored because it offers more desirable uniformity.

4.5 Verification of Alginate Contamination
4.5.1 Experiment
A prepared batch of alginate containing X-gal was stored in a sealed beaker for
seven days. A second batch of alginate was prepared without X-gal, autoclaved for
sterilization, and stored in a sealed beaker for seven days.
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4.5.2 Results
Blue color change was observed in the unsterilized beaker after one week of
storage. The autoclaved alginate/X-gal mixture remained unchanged after one week of
storage; no color change was observed.

4.5.3 Discussion
The blue color change indicated seemingly spontaneous production of the blue
precipitate 5,5'-dibromo-4,4'-dichloro-indigo. Because E. coli or ß-galactosidase had not
been deposited onto or into the prepared alginate, it was unclear what contaminate had
been hydrolyzed by the X-gal within the prepared alginate and then dimerized and
oxidized into the blue product. In order to rule out the possibility of spontaneous color
change without the addition of a ß-galactosidase-expressing contaminate, a sample batch
of alginate was autoclaved, mixed with X-gal, stored for observation. The stability of this
mixture over time indicates contamination of the first alginate by some sort of
contaminate. Sterilization of the alginate mixture prior to the addition of X-gal prevents
foreign contamination and supports the shelf life of an alginate-based solution.

4.6 Alginate Capsule Method and Effect of Induction
4.6.1 Experiment
An experiment was created to verify that the colorimetric reaction is replicable on an
alginate capsule. 3 mm alginate capsules at a 1:1 substrate/alginate ratio were created
using the described manufacturing method in Section 3.2.4.2. A single concentration at
3.16 x 108 CFU/mL and was placed onto the prepared alginate capsules to simply test for
the replication ability. The capsules were allowed to react for 24 hours prior to
observation.

4.6.2 Results
Color change was obtained in the sample after 24 hours. No color change was
observed in the negative control.
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4.6.3 Discussion
Our team determined that our assay is replicable on alginate capsules.

4.7 Validation of Alginate Capsule Method
4.7.1 Experiment
Previously, alginate capsules were created by mixing the anhydrous form of the
substrate X-gal with alginate to create a 1:1 substrate/alginate mixture. To validate the
alginate capsule method and produce more uniform color change through the capsule’s
surface, our team experimented by mixing 20 mg of X-gal in 1 mL of
Dimethylformamide (DMF) to create a stock solution. 19 mL of alginate and 1 mL of
X-gal stock solution were mixed overnight and 3 mm capsules were created using the
described manufacturing method in Section 3.2.4.3. A serial dilution was created ranging
from 108 to 102 CFU/mL and was deposited directly onto the capsules.

4.7.2 Results
Hourly observations were recorded. Significant color change was observed in the
top two concentrations: 108 CFU/mL and 107 CFU/mL.

4.7.3 Discussion
The replicability of our entire assay on various concentrations of E. coli contaminated
milk was clear, however our assay clearly had flaws. In the time period that we recorded
observations, we saw minimal color change. In previous experiments, our team witnessed
qualitative results in lower concentrations, and in this experiment, we did not observe the
same robustness of our assay. While we were able to conclude that our assay is replicable
on the dilution ladder, it also displayed flaws in our assay design.
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4.8 Optimization of Induction for Cell Growth
4.8.1 Experiment
In effort to optimize the production of our enzyme ß-galactosidase, our team
optimized our cell growth process to find the ideal milk induction volume. Twelve
different tubes of cells were incubated with varying milk volumes: 0, 20, 40, 60, 80, and
100 µL. Six dilutions were created in water and six dilutions were created in milk to
compare our results from a relevant experiment environment to an ideal experiment.
Serial dilutions were created by creating samples with various concentration of E. coli
cells ranging from 108 to 102 CFU/mL. All cells were lysed using the B-PER lysis
protocol. 100 µL of each sample was deposited into a 96-well plate and observed hourly
for 8 hours.

4.8.2 Results
An intense blue color change was observed in top two concentrations in all
dilutions. Observations were recorded hourly for an 8 hour period and were observed
again after 24 hours.

4.8.3 Discussion
While an intense blue color change was observed in all dilutions in the top two
concentrations at 108 CFU/mL and 107 CFU/mL, the dilution with a milk induction
volume of 100 µL produced the most intense blue color. Though we optimized the milk
induction volume, we saw flaws with the results we obtained. In previous experiments,
we witnessed color change in concentrations much lower than the threshold obtained
from this experiment, detecting around 104 CFU/mL in comparison to the observed 107
CFU/mL. In the time period that we recorded observations, we saw minimal color
change. In previous experiments, our team witnessed qualitative results in lower
concentrations, and in this experiment, we did not observe the same robustness of our
assay. While we were able to conclude that the milk induction was optimized further
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towards the ideal condition, our experiment also displayed significant flaws in our assay
design.

4.9 Optimization of Sample Volume for Detection Intensity
4.9.1 Experiment
To determine the ideal volume of milk sample necessary to achieve optimum blue
color change, the sample volume of contaminated milk added to the prepared alginate
capsules was varied. Serial dilutions were created by creating samples with various
concentration of E. coli cells ranging from 108 to 102 CFU/mL. All cells were lysed using
the B-PER lysis protocol. 20, 40, 60, 80, and 100 µL of inoculated milk dilutions were
deposited onto the capsules in a 96 well plate and observed after 8 hours.

4.9.2 Results
The blue color change increased in intensity as the volume of milk increased; the
most intense blue color was produced in the wells containing 100 µL.

4.9.3 Discussion
Although this result reflects the understanding that a more intense blue
corresponds to a greater volume of contaminant, it also indicates that the minimum
volume of sample required to produce a reaction observable by the human eye. The most
intense blue color change with 100 µL informs the protocol for the end user. 100 µL of
sample enables the alginate capsule to be fully emerged and thus take advantage of all of
the substrate XG that diffuses out of the capsule—hypothetically radially—and reacts
with the ß-galactosidase in the milk.

4.10 Optimization Runs (4-level, 5-variable)
4.10.1 Experiment
In order to determine which variables had the greatest impact on the reaction
overall, an L16 Taguchi orthogonal array experiment was conducted with a
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“larger-the-better” optimization goal.55 This factorial design entails a four-level,
five-variable array of different combinations of the variables. The formulae needed to
determine the optimized level of parameters based on the sensitivity (Sm), signal to noise
ratios (S/N), difference (D), and rank (R) using larger-the-better-optimization are given in
Equations 1–4.

where i corresponds to the level, j corresponds to the factor, and L is the total number of levels.
Rank, R is given by:

Signal-to-noise ratio (dB) for the jth experiment, (S/N)j is given by:

where n is the total number of replicates per experiment, and Ymj is the measured viability for the
mth trial of the jth experiment. For the purpose of our timeline, only one experiment was
completed using the Taguchi method.
Sensitivity (dB) for the jth experiment (Sm)j is given by:

The variables that were analyzed include the volume of milk added to the cell growth
tubes for induction, the volume of X-gal substrate added to individual capsules, the lysing
incubation time, the temperature at which the reaction took place, and the concentration of E.
coli cells in the milk sample. The volumes of milk added for induction included 0, 50, 100, and
150 µL. The lysing incubation times included 10, 15, 20, and 25 minutes. The temperatures
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included 23, 37, 40, and 45ºC. The concentration of E. coli cells included 3.16 x 105, 106, 107,
and 3.16 x 107 CFU/mL. 16 combinations of these five variables were prepared for deposition on
alginate capsules and observed hourly for 10 hours.

4.10.2 Results
Two combinations of variables that produced the most intense blue color in the
shortest amount of time were identified: Combinations G and M. “G” consisted of 50 µL
milk for induction, 20 minutes of lysing incubation time, 100 µL X-gal, 37ºC reaction
temperature, and 3.16 x 107 CFU E. coli/mL milk sample. “M” consisted of 150 µL milk
for induction, 10 minutes of lysing incubation time, 100 µL X-gal, 40ºC reaction
temperature, and 3.16 x 107 CFU E. coli/mL milk sample. Although another combination
produced a comparatively dark blue color, it was not identified as a desirable
combination because it took longer for the color to develop and it required a 45ºC
reaction temperature, which would require the end user to spend more energy and money
to maintain a warmer temperature that is less common in conventional laboratory
settings. S/N charts can be seen in Appendix VII.
4.10.3 Discussion
This Taguchi experiment allowed for the optimization of possible combinations
for the given five variables. To reduce the number of experiments to a practical level and
obtain the most information, only five variables were tested. From the 16 possible
combinations, two favorable ones were observed and selected for confirmation runs (4.11
Confirmation Runs).
Additionally, the most important variables could be identified using the
Signal-to-Noise ratios of each of the variables. The variables that have the greatest impact
on the reaction are volume of milk for induction, E. coli concentration, and temperature
at which the reaction takes place, whereas the lysing incubation time and substrate X-gal
concentration have less of an impact on the outcome. We can infer this by looking at the
absolute value of the S/N ratio for each variable as well as the difference between each
variable’s highest and lowest S/N ratio value. A higher absolute value determines a
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variable to be more significant. A greater difference in S/N ratios among different
conditions for one variable also determines that variable to be more significant in
producing blue color at a lower limit of detection in a shorter amount of time.

4.11 Confirmation Runs
4.11.1 Experiment
Experiment 4.10 was repeated with the two best performing combinations G and
M. Three replicates of each of the combinations were prepared. Instead of limiting the E.
coli concentrations to the four original ones chosen in the previous experiment, full
dilutions ranging from 10-108 CFU/mL as well as a control with no contamination were
prepared. These dilutions were prepared for deposition on alginate capsules and observed
hourly for 10 hours.

4.11.2 Results
The blue color change was more intense and over the same amount of time in
combination M than in G. No blue color change was observed on the control alginate
capsule.

4.11.3 Discussion
This experiment confirmed that the procedure was replicable and clarified that the
second combination M (150 µL milk for induction, 10 minutes of lysing incubation time,
100 µL X-gal, 40ºC reaction temperature) produced the most ideal results. This guided
the current protocol for the use of the sensor. The shorter incubation time reduces overall
time for detection and the 40ºC reaction temperature is feasible in milk bank and
laboratory settings that already have an incubator or alternative heat source in their
possession.
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4.12 Verification of Optimization on Alginate Capsules
4.12.1 Experiment
Experiment 4.11 was repeated with only combination M on alginate capsules.
B-PER protocol had been employed in experiment 4.11 Confirmation Runs for its
shorter time and overall ease, but given the superiority of the Miller permeabilization in
experiments 4.3 Effect of Substrate Concentration in Alginate Entrapment and 4.4
Evaluation of Uniformity of Color Diffusion in Alginate on alginate slabs. Thus, the
two lysing procedures were also compared on alginate capsules using the identified
optimal combination of factors.Full dilutions ranging from 10-108 CFU/mL as well as a
control with no contamination were prepared. These dilutions were prepared for
deposition on alginate capsules and observed hourly for 10 hours. Images of the wells
were taken eight hours after the completion of the the protocol and image analysis was
performed using ImageJ.

4.12.2 Results
More intense blue color changed was achieved in eight hours using the B-PER
protocol as opposed to the Miller protocol. A spectrum key was generated corresponding
the blue color to the E. coli concentration.
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Figure 6. The Quantified Results of Current Prototype Replicates. Using our quantified, replicable data, we were
able to generate a color spectrum that more accurately represents the color change at various concentrations of
bacterial contamination.

4.12.3 Discussion
As the concentration of the E. coli in the milk increased, so the did the color
intensity of the captured image of the sensor well. The alginate capsule sensors produce
the expected result. The negligible standard deviation on the 1 CFU/mL wells indicates
that the sensor is highly sensitive. The significant separation between standard deviations
on the lower E. coli concentrations (10-103 CFU/mL) further supports the sensor’s
sensitivity. The overlapping standard deviations for the middle E. coli concentrations, as
reflected by the similar blue shades of color that are difficult to differentiate via the
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human eye, indicate the variability introduced by the image capture method. Ambient
lighting and light refraction through the plastic of adjacent wells in the well plate prevent
more distinct blue color from being captured.

CHAPTER 5: COSTING ANALYSIS
Overall, the project fell within the budget and is comparable to current industry costs for
bacterial culturing and screening in Mumbai, India according to research conducted at Sion
Hospital.

Cost estimates for production using the small-scale materials were derived and are outlined in the
table below. The complete product includes the gel capsule prototype, which consists of the
X-gal and alginate, in conjunction with the two lysing protocols.

Table 6. The cost estimates for a single use of a complete sensor product.

Cost Per Sensor Using Miller
Protocol ($)

Cost Per Sensor Using B-PER
Protocol ($)

XG

0.0003

0.0003

Alginate

0.0047

0.0047

Lysing Protocol

0.0410665

0.31

0.046

0.32

Although the Miller protocol makes the complete product dramatically cheaper, both the Miller
protocol and the B-PER protocol fall under the target cost of $1.00 per sensor. While the Miller
protocol would make pricing not only competitive but also cheaper than the current practice of
bacterial culturing, it is not particularly user-friendly and frugal. A lab technician may need
special training for the careful handling of hazardous chloroform, and it requires a hood. The
price of a product utilizing B-PER for lysis is competitive with the cost of current detection
methods.
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CHAPTER 6: ENGINEERING STANDARDS AND REALISTIC
CONSTRAINTS
6.1 Ethical Justification: Lack of Research
Breast milk is known throughout the medical community as the best source of nutrition
for infants with countless benefits compared to alternatives such as formula. Though a key
source of factors that can aid in development and growth, like the previous team, our team
encountered an astounding lack of research surrounding breast milk diagnostics and related
banking systems. To further the dedication that last years’ team made to narrowing the
knowledge gap, our team also devoted ourselves to enhance the scientific knowledge
surrounding breast milk.

6.2 Importance of Ethics for MilkGuard
Our team dedicated ourselves to creating a technology that was both scientifically and
ethically sound to produce the most accurate, safe, and applicable device to the unmet medical
need. The project surrounds an industry that caters directly to those affected by the greatest
risk--infants. Below are ethical considerations regarding team organization, product design, and
cultural and social ethics:

Table 7. Team Organization to Uphold Project Ethics

Ethical Consideration

Established Practice

Team Member Ethics

Established Weekly Meetings
Weekly meetings were established to ensure that all team
members were kept accountable and up to speed with the
project. Each meeting was documented with an agenda and
thorough minutes taken on a rotating schedule.
Lab Etiquette
Team members worked to establish lab times that were
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consistent for a majority of or all team members. This
allowed for thorough collaboration and effective, equal use of
lab time.
Team Member Contributions

Collaborative Environment
All team members were encouraged to share opinions, ideas,
and creativity with the team. While team members may have
differing opinions, the group was dedicated to staying
open-minded and considering all possible perspectives of the
team.
Delegation of Tasks
Team members divided certain tasks and became Subject
Matter Experts (SME) in specific areas of the project.
Whether taking charge of communication with a specific
partnership or leading a step during lab time, each member
was tasked to staying up to date with the specific subject area.

Ethical Partnership Building
and Management

Contact with Advisors and Collaborators
The team met with highly involved advisors at least once a
week to maintain positive trajectory towards team goals.
Collaborators and partnerships were contacted periodically to
maintain relationship and provide necessary updates.
Establishment of New Contacts
The team traveled to the Bay Area Global Health Innovation
Conference on May 4 - 5. Here, the team interacted with
organizations and professionals in the global health sector to
establish greater connections and collaborations within the
field.
Partnership with Engineering World Health (EWH)
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The team worked closely with the Engineering World Health
students to maintain a positive and efficient relationship.
Clear goals and tasks were assigned to team members to
ensure that both parties were equally as invested in the
project’s impact.

The National Society of Professional Engineers’ Code of Ethics for Engineers56 and the World
Health Organization’s (WHO) Guide for Open Point-of-Care Diagnostic Platforms for Low to
Middle Income Countries57 were consulted to ensure that our design met criteria applicable in
our target setting.

Table 8. Product Design Ethics

Ethical Consideration

Established Practice

Result Reporting and
Experiment Reproducibility

Lab Notebooks and Related Electronic Documents
Each member was required to record results physically in lab
notebooks and results and experiment design were transferred
into an electronic log of experimentation. Results and
experiments were overseen by Dr. Craig Stephens, Dr. Ashley
Kim, and Dr. Maryam Mobed-Miremadi as acting advisors,
professionals, and collaborators on the project.
Experiment Reproducibility
Experiments were conducted in sets of three replications to
confirm results and experimental design. Results were
quantified using ImageJ and standard deviations were
calculated to analyze result deviations from the norm.

Nspe.org. (2018). Code of Ethics | National Society of Professional Engineers. [online] Available at:
https://www.nspe.org/resources/ethics/code-ethics [Accessed 14 Jun. 2018].
57
Who.int. (2018). [online] Available at: http://www.who.int/phi/Open_DX_Platform_WHO_Call_for_Interest.pdf
[Accessed 14 Jun. 2018].
56
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Breast Milk Handling

Donor Confidentiality
Breast milk samples were obtained through the Human Milk
Banking Association of North America (HMBANA) through
a research application. Raw and pasteurized milk was
requested without donor information such as demographics
and key identifiers. Sample labels were kept confidential to
allow for blind experimentation free of biases.
Mother’s Milk Bank of San Jose Partnership
The team visited Mother’s Milk Bank of San Jose to build
and maintain a relationship with the director. Per request, the
team obtained sensitive information and agreed to keep it
confidential as we used it to guide the sensitivity of our
product.
Sample Handling
Breast milk treated as a hazardous material in lab and
followed all applicable waste handling protocols.

Table 9. Cultural and Social Ethics

Ethical Consideration

Established Practice

End User

World Health Organization/Engineering World Health
In an effort to meet parameters established by the World Health
Organization and Engineering World Health, costs were kept
low, user-friendliness was improved, and sensor robustness was
improved. Doing so will allow it to be more economic and will
open up distribution to allow for greater access in low-resource,
vulnerable areas.

Global Health Awareness

Partnerships
The team worked directly with PATH. This organization works
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to establish milk banks in low resource settings, so they acted
as guidance to ensure that our sensor is functional in the
industry.
Field Research
Two team members traveled to Sion Hospital in Mumbai, India.
By traveling to a low-resource setting where breast milk banks
are prevalent, greater design constraints and criteria were
developed to further the applicability of the project.
Maternity

Breastfeeding Culture
The goal of the project is to promote breastfeeding and breast
milk donation so that all infants may have access to such
nutritional content.
Maternal Integrity
In effort to promote breastfeeding, our team considered the
ethical ramifications of informing mothers of their milk’s
nutritional content and potential contamination. Our goal is not
to dissuade mothers from breastfeeding or breast milk donation,
so we collaborated with PATH to maintain the ethical integrity
of the project’s result documentation and communication.

6.2.1 Potential Risk Modes and Analysis
To address potential failure risks that may result from our product, a Failure
Modes Effects and Analysis was conducted to identify key factors that may result in the
failure in the device and the related severity of such failure. The following were
identified as the greatest sources of failure risk:
● Milk Volume Added
● Cross-Contamination
● Device Reuse
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● Lack of Access to Higher Temperatures
While not all of these failure risks were completely addressed by the team, next steps
were explored in order to address such risks.
6.2.1.1 Potential Failure Modes and Analysis: Milk Volume Added. While this
variable is key to the experimental design in vivo, it is not as applicable within a clinical
lab setting. In industry, samples are composed entirely of breast milk and related factors,
and small milk volume additions are not applicable in a greater testing facility. This
factor is key to experimental design but is not applicable in an industry setting.

6.2.1.2 Potential Failure Modes and Analysis: Cross-Contamination.
Cross-contamination is a crucial failure mode of our device. Currently, the
specificity of our bacterial contamination is unknown. Because our device relies on an
enzyme-substrate reaction specifically for E. coli bacteria with an intact LacZ operon and
our team specifically inoculated our milk samples with known concentrations of bacteria,
we know that our device is applicable with such related bacteria. However, our device is
currently not applicable to other species of bacteria that do not rely on such
enzyme-substrate reaction.
Our team confirmed that substrate entrapped within a cross-linked alginate matrix
allowed for molecules to retain their bioactivity to allow for the enzyme-substrate
reaction to take place. Since this method was verified, we anticipate that this mechanism
is applicable on a greater scale to other related contaminants. For future work, individual
alginate capsules can be manufactured with specific enzymes entrapped in them. These
capsules will then act like chambers on the sensor to be able to detect multiple areas of
contamination, thus, allowing for a more specificity and reduction of false results due to
cross-contamination.
6.2.1.3 Potential Failure Modes and Analysis: Device Reuse. Our device functions as a
single-use product. Originally having an opaque coloration, the device changes to a
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permanent, stark blue. This color change is irreversible, so it does not allow for the reuse
of the MilkGuard product. Because of this stark color change, we anticipate that users
will know that our device are single-use products.

6.2.1.4 Potential Failure Modes and Analysis: Lack of Access to Higher
Temperatures. Our device produces optimal results at 8 hours given that the reaction is
allowed to take place at 40°C. Our team is aware that not all laboratories have access to
electricity and power to allow for certain equipment to function indefinitely. Therefore,
our team explored other potential biomaterials that will reduce the need for such higher
temperatures. We are aware that there are biomaterials that retain a greater potential
energy, which reduces the need for consistent access to these higher temperatures.

6.3 Engineering Standards for Consideration
According to the National Society of Professional Engineers’ Code of Ethics for
Engineers, professional engineers must take into consideration the impact of our design in the
areas of ethics, science, technology and society, civic engagement, economic, health and safety,
manufacturability, usability, sustainability, and the environmental impact. Such considerations
must be considered to ensure that the technology not only benefits the consumer, but also
prevents negative impact on the surrounding community. The following delineates MilkGuard’s
potential impact in a selection of these areas.

6.3.1 Ethical Considerations
When meeting with breast milk banking experts and maternal and infant health
experts, they highlighted the importance of supporting and praising mothers for their
breast milk. They clearly explained that the results of the testing and diagnostic device
should not make a mother feel inadequate or deficient in either her breast milk expression
or the nutritional quality of her milk. There is an obvious ethical obligation that our team
has to not demean or devalue mothers whose milk is not as nutritious as anothers.
MilkGuard is not a device that should cause harm or worry for mothers. Instead, it is
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designed as a tool to improve testing capabilities of breast milk in order to detect for
bacterial contamination. While the origin of contamination may come from a variety of
sources, the most important factor is the device will ensure that the breast milk delivered
to at risk infants. As the project continues, it is crucial that ethical obligations are upheld
so that mother and infant are encouraged to consistently donate safe breast milk.

6.3.2 Social Impact
Though breast milk banking is prevalent in some countries, like India and Brazil,
it is extremely uncommon within the United States. MilkGuard’s research will fill a
knowledge gap surrounding this industry, and can increase awareness and accessibility of
these breast milk banks worldwide. With greater and more developed research and
technology within this sector of maternal health, woman can be empowered to further
support breastfeeding and breast milk donation.

6.3.3 Health and Safety
MilkGuard is an extremely simple and easy-to-use diagnostic device that will be
used primarily by lab technicians with sufficient training in lab settings. Currently, it is
not meant to be used by any mothers or related consumers. It is not meant to be ingested,
nor is it toxic to human touch. The biomaterials used are bioinert, so it will not cause any
reaction when in contact with human tissue. In addition, all biomolecules used are used in
small trace amounts when constructing the device, and these do not pose an immediate or
severe health and safety risks to the end-user.
6.3.4 Regulatory Requirements58
According to the Food and Drug Administration, non-invasive diagnostics can be
considered Class I Devices. Class I devices can be defined as simple devices that pose
low potential for harm on the end-user. In an effort to better understand the regulatory

Fda.gov. (2018). Class I / II Exemptions. [online] Available at:
https://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/Overview/ClassifyYourDevice/ucm051549.ht
m [Accessed 14 Jun. 2018].
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space, our team consulted John Petrovich, CEO of the Alfred Mann Foundation, at the
Bay Area Global Health Innovation Challenge. His feedback reinforced our assumption
that MilkGuard would be considered a Class I device if our team decided to pursue FDA
approval. Though there are FDA and ISO standards that must be met for medical devices,
because our product is considered a Class I device and is completely non-invasive, it does
not need to go through certain forms of testing, like biocompatibility or toxicity testing.

6.3.5 Economic Considerations
MilkGuard is designed to be deployed in low to middle income countries,
therefore it was designed to be as low-cost as possible. While originally developed on a
paper-based platform to reduce costs, our team transitioned to a polymer-based platform
because an inexpensive, organic biomaterial was selected and exceptionally reduced the
complexity of the sensor. The following is a cost-breakdown of the unit price of a single
sensor:

Table 10. Cost-breakdown of a Single Sensor

Items

Cost Per Sensor ($)

Alginate

0.0003

XG

0.0047

Lysozyme

0.08

DNAse

0.1456

B-PER

0.086

Total

0.32

6.3.6 Manufacturability
In a previous design, the sensor was constructed with three bands, each with
several layers deposited. Additionally, it utilized a lateral flow method in order to allow
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the desired enzyme to travel through the porous filter paper. Since transitioning from the
silica sol-gel entrapment mechanism to an alginate capsule entrapment method, the
manufacturability of this device increased exponentially. Once mixed with the X-gal
substrate, the alginate capsules can be manufactured uniformly utilizing a syringe pump
which allows for the process to be extremely high-throughput. Such process will allow
for the rapid and uniform production of the desired alginate capsules which can then be
easily deposited directly onto the device’s platform before use.

6.3.7 Usability
The design currently requires that trained lab technicians conduct the testing. To
be a true point-of-care device in a low to middle income setting according the World
Health Organization, the device must be extremely user-friendly. Though the device does
require that the milk samples be pre-treated prior to deposition on the device, the sensor
is extremely simple and can be easily used even in low-resource settings where
professionals may not experience the same training modules as their counterparts in high
income settings.

6.3.8 Environmental Impact
MilkGuard is a single-use sensor that is easily disposable without complex or
extensive hazardous waste protocols. Because this design iteration transitioned to a
alginate-based platform, the environmental impact of our device has decreased. Alginate
is an organic biopolymer that is a derivative of algae, so it is easily disposed of. In
addition, little amounts of reagents are used within the sensor, so as a whole, it does not
have extensive effects on the surrounding environment.
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CHAPTER 7: SUMMARY AND CONCLUSION
7.1 Project Summary
MilkGuard began as a project to streamline the testing required within the breast milk
banking system. It was centered around advocating for greater maternal health technologies and
increased awareness of the importance of breast milk across the globe. When the project was first
passed down to our team, it had a limit of detection of 105 CFU/mL and utilized a more complex
design. Since then, our team made numerous iterations to the design to meet goals originally
created at the beginning of the project’s duration. By utilizing a different enzyme-substrate
reaction for the detection of ß-galactosidase to measure the concentration of E. coli bacteria, we
anticipate that the sensor’s mechanism can now be applied to other bacterial contaminants. In
addition, our team identified and optimized the use of an alginate biomaterial, which allowed for
a drastic simplification in the sensors design and manufacturability. Lastly, our team optimized
the conditions at which we conducted our experiments to find the conditions that results in the
greatest signal. The combination of a different detection method, new biomaterial, and optimized
conditions allowed for the sensitivity of our sensor to increase to 10 CFU/mL.
Additionally, to further the project’s goal of increasing awareness about the importance
of breastfeeding and breast milk donation, our team worked to capture new audiences with our
project’s impact. In May, our team participated and presented in the Bay Area Global Health
Innovation Challenge where we networked with established global health organizations and
professionals. In addition, our team maintained relationships with organizations like PATH and
EWH to ensure that our message impacted those currently in related industries, and we
established new contacts with other related organizations, like D-REV, a non-profit organization
focused on distributing world-class affordable technologies to those in need, to help further the
development and deployment of MilkGuard.
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7.2 Future Work
7.2.1 Shelf Life Assessment
The shelf life of the X-gal substrate lyophilized in the alginate gel needs to be
assessed in order to figure out how long the substrate will remain effective for use in a
reaction with ß-galactosidase.

7.2.2 Image Capturing
Currently, iPhone cameras are used in conjunction with ImageJ to analyze the
blue color intensity in the alginate gel and solution. A standardized, high quality method
of image capturing and analysis needs to be implemented in order to ensure the
confidence of our device’s lowest limit of detection. Further methods could include the
use of high quality cameras, lights, and microscopes for efficient image capture.

7.2.3 Diffusion Characterization
We would like to mathematically characterize the diffusion of X-gal out of
alginate when in contact with a solution containing ß-galactosidase. This research would
allow us to determine aspects that significantly affect the diffusion rate so that we can
optimize the sensor’s design to work around such constraints. This characterization will
help improve the sensor’s efficiency and effectiveness.

7.2.4 Detecting Multiple Contaminants
Ideally, our device would be able to detect all of the common contaminants in
breast milk banks. The most common contaminant is Bacillus cereus. Our device would
need to be able to detect Bacillus cereus at a high sensitivity in order to be used in breast
milk banks. Staphylococcus is another top concern at milk banks in which we hope to be
able to detect.
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7.2.5 Field Testing
We would like to connect with multiple banks in varying geographical areas and
resource settings to understand exactly how our device would fit into their respective
milk banking systems.

7.3 Lessons Learned
The project provided an educational experience through which we developed the ability
to design, plan, and execute experiments. In the face of ambiguity or contradicting results from
multiple experimented, we learned to identify and troubleshoot different variables to adjust and
test in subsequent experiments. This process strengthened our perseverance and persistence.
Our challenges largely stemmed from our overall lack of experience in a research
laboratory setting. Because we came from pre-medicine and medical device tracks, we were less
familiar with the bioengineering labs and the handling and storage of materials in the labs. A
significant portion of the fall quarter was spent developing skills and familiarizing ourselves with
the protocol established by the previous year’s team. In doing so, we faced difficulty printing the
multiple layers of the sensor using the inkjet printer and the volumetric dispenser. The printer
was not designed to print more viscous fluids like the polyvinylamine, and the volumetric
dispenser was considerably time-consuming.
This challenge hindered efficient manufacturability, ultimately influencing us to explore
alternative methods of entrapment and sensor construction. Later, we ran into a problem with the
performance of our assay, which we attribute to the somewhat unpredictable and adaptable
nature of cell behavior. The same blue intensity was not achieved in low concentrations of E. coli
dilutions using the same cell line that we had been using. This led us to eliminate the possibility
of contamination, re-plate the cells, and conduct the optimization experiment, which produced
particularly valuable feedback.
Our latest challenge involved our method of image capture. We opted to start with an
iPhone camera for sake of ease, time, and availability as each of our three team members own
one. However, iPhone cameras are programmed to automatically adjust exposure settings, thus
preventing consistency across data collection at different time periods by different team members
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using different iPhones. Additionally, the sensors were located in a plastic well plate in which
adjacent wells contained different dilutions of contaminant. Ambient lighting throughout the
plate as well as light refraction from sensors in adjacent wells interfered with the intensity values
captured by the camera.
Finally, we shared a lot of the same strengths as a team. But, we struggled to reconcile
some of our differences. Sometimes, we opted to forego preparatory critical thinking and trust
that running an experiment would yield informative results. Other times, an analytical thought or
perspective postponed an experiment in effort to critically evaluate the purpose and design of an
anticipated experiment. Eventually, we struck a balance between this critical thinking and
acceptance with ambiguity before moving forward with our experiments.
We also connected with professionals across a variety of departments (i.e. Public Health,
Biology, Physics, and Bioengineering). We effectively leveraged their expertise and synthesized
their input throughout our experimental protocol and innovation design. When confronted with
little or slow progress, we did not limit ourselves to narrow or obvious ideas. In fact, our
exploration of alternative approaches led to our new entrapment and production method
altogether. These strengths were all brought about in our hard work throughout the year.
Ultimately, this discipline enabled us to passionately communicate our work and vision. And, it
enabled the dramatic simplification of the sensor’s design as well as expanded manufacturing
feasibility and scalability.
Simultaneously, we recognize that we need to further reduce the limit of detection
(LOD), improve the color change intensity, extend shelf life and storage viability, expand the
sensor to detect additional contaminants, enhance specificity, and further develop the image
capture method.
Overall, we encourage future teams to remain open to new approaches, diversify a team’s
specialties and strengths, dedicate significant time and patience to learning proper and efficient
lab skills and protocol, and work with the Engineering World Health team to quantify the social
impact of a market-ready product. Finally, an effective team will embrace frequent, clear, and
concise communication throughout the design process—and have fun doing it!
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APPENDICES
APPENDIX I: COMPLETE MATERIALS LIST AND BUDGET
The original budget was $1,855.05 dollars for materials. The Santa Clara School of Engineering
grant and Engineering World Health grants provided us with $1,500 and $1,000 respectively.
Table 11. Complete Budget and Materials List.

Item

Use

Source

Price ($)

Human breast milk Sample

Mother’s Milk Bank (San Jose,
CA)

BL21 Escherichia
coli cells

Detection pathogen

Dr. Jonathan Zhang, Santa Clara
University (Santa Clara, CA)

0

Bacterial growth medium

Sigma Aldrich (St. Louis, MI),
purchased by previous team

0

E. coli cell lysis

Thermo Fisher Scientific
(Waltham, MA)

Detection platform

Sigma Aldrich (St. Louis, MI),
purchased by previous team

LB Broth
B-PER Direct
Bacterial Protein
Extraction Kit
Whatman
qualitative filter
paper, Grade 1

800

221

0

Polyvinylamine
Polymer activates paper;
(PVAm) (Lupamin provides adhesive support for
9095)
sol gel layers
BASF (Mississauga, Canada)

0

X-gus
(5-Bromo-4-chloro3-indolyl-β-D-gluc
uronide sodium
Substrate for E. coli enzyme
salt)
β- glucuronidase (GUS)

Sigma Aldrich (St. Louis, MI),
purchased by previous team

0

X-gal
(5-Bromo-4-Chloro Substrate for E. coli enzyme
-3-Indolyl
ß-galactosidase

Thermo Fisher Scientific
(Waltham, MA)

78

190

β-D-Galactopyrano
side)
Sodium silicate
solution (SS)

Thomas Scientific (Swedesboro,
NJ)

Sol-Gel precursor

Tetraethyl
orthosilicate
(TEOS)

Used with anhydrous glycerol
to synthesize Diglyceryl
Silane (DNS) (Sol-Gel
Sigma Aldrich (St. Louis, MI),
precursor)
purchased by previous team

Dowex 50WX8
hydrogen form

Cation exchange resin
replaces Na+ with H+ in SS
sol preparation

Sigma Aldrich (St. Louis, MI)

88

Used with TEOS to
synthesize DNS; 30% added
to solutions to adjust
viscosity/surface tension for
Anhydrous glycerol ink-jet printing

Sigma Aldrich (St. Louis, MI),
purchased by previous team

0

Iron chloride

Sigma Aldrich (St. Louis, MI),
purchased by previous team

0

Component of the
Methytrimethoxysil hydrophobic barrier:
ane (MTMS)
Methylsilsequioxane (MSQ)

Sigma Aldrich (St. Louis, MI)

36.3

Ethanol (EtOH)

MSQ synthesis

Bioengineering Department,
Santa Clara University (Santa
Clara, CA)

0

Hydrochloric Acid
(HCl)
MSQ synthesis

Bioengineering Department,
Santa Clara University (Santa
Clara, CA)

0

Buchner Funnel

Chemistry Department, Santa
Clara University (Santa Clara,
CA)

0

Oxidizing reagent

SS-gel synthesis
79

47.75

0

Syringe Filter,
0.45-μm

SS-gel synthesis

EMD Millipore (Hayward, CA),
purchased by previous team

0

Syringe, 5 ml

SS-gel synthesis

Bioengineering Department,
Santa Clara University

0

E. coli Antibody
(20- ER13)

Conjugated to magnetic beads Fitzgerald (Acton, MA),
for E. coli preconcentration
purchased by previous team

0

Conjugated to E. coli
Hydrazide-Modifie antibodies for E. coli
d Magnetic Beads preconcentration

Bioclone (San Diego, CA)

Phosphate buffer
saline (PBS),
NaH2PO4

Storage buffer for MB-Ab
coupling

Bioengineering Department,
Santa Clara University (Santa
Clara, CA)

Epson Stylus C88
Inkjet Printer

Improve manufacturability of Best Buy (Richfield, Minnesota),
layering molecules
purchased by previous team

0

Ink cartridges

Improve manufacturability of Amazon (Seattle, WA),
layering molecules
purchased by previous team

0

Chloroform

Used in Miller protocol for
permeablization (replaces
lysing)

Bioengineering Department,
Santa Clara University (Santa
Clara, CA)

0

0.1% Sodium
dodecyl sulfate
(SDS)

Used in Miller protocol for
permeablization (replaces
lysing)

Bioengineering Department,
Santa Clara University (Santa
Clara, CA)

0

Lysozyme

Used in lysing process in
tangent with B-PER

Thermo Fisher Scientific
(Waltham, MA)

50

DNAse

Used in lysing process in
tangent with B-PER

Thermo Fisher Scientific
(Waltham, MA)

91

80

250

0

ß-Galactosidase
from Escherichia
coli

Positive control for X-gal ß-gal reaction

Sigma Aldrich (St. Louis, MI)

81

Alginate powder

Used with 0.9% NaCl
solution to make alginate
hydrogel

Bioengineering Department,
Santa Clara University (Santa
Clara, CA)

0

Used to crosslink alginate
1.5% CaCl solution hydrogel

Bioengineering Department,
Santa Clara University (Santa
Clara, CA)

0

Used with alginate powder to
make alginate hydrogel.
Bioengineering Department,
Also used to stop crosslinking Santa Clara University (Santa
0.9% NaCl solution of alginate.
Clara, CA)

0

1 mL syringe

Used to make alginate
capsules

Bioengineering Department,
Santa Clara University (Santa
Clara, CA)

0

18G 1 ½ inch
precision needle

Bioengineering Department,
Used with with 1 mL syringe Santa Clara University (Santa
to make alginate capsules
Clara, CA)

0

Cell strainer

Bioengineering Department,
Used to filter alginate
Santa Clara University (Santa
capsules out of CaCl solution Clara, CA)

0

Total:

81

1855.05

APPENDIX II: GANTT CHART AND DESIGN PROCESS TIMELINE
Task

Sept.
2017

Oct.
2017

Nov.
2017

Dec.
2017

Identify Problem
Statement
Familiarize with 2016-17
Team's Experimental
Protocols and
Instrumentation
Take Inventory and
Order Materials
Field Research at Milk
Banks
Understand Customer
Needs and Establish
Criteria
Review of Literature and
Exploration of
Alternative Solutions
State Project Goal and
Objectives
Submit Proposal for
Undergraduate Programs
Funding
Replicate Previous
Team's Assay in Water
Buffer
Conceptual Design
Iteration
Write Thesis
Introduction
Conduct Assay in
Donated HBM
Simulate Sensor in Well
Assay
Optimize Lysing
Procedures
Print Sensor Layers
Using HP Volumetric
Dispenser
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Jan.
2018

Feb.
2018

Mar.
2018

Apr.
2018

May
2018

June
2018

Test Feasibility of
Alginate Entrapment
Apply to Bay Area
Global Innovation
Challenge
Run Experiments to
Optimize Detection
Optimize
Enzyme-Substrate
Reaction in Alginate
Slab and Capsules
Prepare for BAGHIC and
Senior Design
Run Final Experiments
with Improved Image
Capture
Train New Team in Lab
Figure 7. Gantt chart timeline and project deadline goals. This Gantt chart helped our team map out our project
goals for the year and established strict deadlines for us to meet. These deadlines allowed our team to act efficiently
and timely with all submissions.

Figure 8. Design process timeline. MilkGuard’s design process timeline helped us establish realistic goals in lab
milestones and solutions to ensure we met deadlines and aspirations created in the Gantt chart (Figure 6).
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APPENDIX III: ß-GALACTOSIDASE AND X-GAL REACTION

Figure 9. X-gal/ß-galactosidase reaction. When reacting with ß-gal, the X-gal will cleave and hydrolyze. The
hydrolysis will allow for the formation of a blue precipitate that our sensor utilizes to indicate the concentration of
bacterial contamination.

APPENDIX IV: PREVIOUS ENTRAPMENT MECHANISMS AND
FABRICATION
Silica Sol-Gel
Silica Sol-Gels can entrap and immobilize biomolecules on paper platforms. Silica’s lattice
structure stabilizes biomolecules without affecting their physical properties or chemical
structure. These gels can also be loaded into inkjet printers and easily and rapidly deposited onto
paper without altering its chemical structure.59
Preparation and Construction of Silica-Sol Gel Sensor
To prepare the silica sol-gel, 10 mL of ddH20 were mixed with 2.9 g of sodium silicate
solution to obtain a pH of 13. 5 g of Dowex cation exchange resin were added to the mixture to
replace Na+ with H+. The mixture was stirred for 30 seconds to reach a final pH of 4. The gel was

59

S. M. Zakir Hossain, Roger E. Luckham, Anne Marie Smith, Julie M. Lebert, Lauren M. Davies, Robert H.
Pelton, Carlos D. M. Filipe, and John D. Brennan. Development of a Bioactive Paper Sensor for Detection of
Neurotoxins Using Piezoelectric Inkjet Printing of Sol−Gel-Derived Bioinks. Analytical Chemistry 2009 81 (13),
5474-5483. DOI: 10.1021/ac900660p
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vacuum-filtered through a Buchner funnel. That filtrate was filtered the filtrate through a
0.45-um membrane syringe filter.60 To prepare the X-gal stock solution, 20 mg of X-gal was
dissolved in 1 mL dimethylformamide. The polyvinylamine (PVAm) was used in its pure form.
To prepare the sensor, each of the layers were sequentially pipetted onto the paper within
a well plate such that the entire surface of the well was coated in the fluid. The layers were
deposited in the following order: 20 µl PVAm, 20 µl silica sol-gel, 5 µl X-gal, 20 µl silica
sol-gel. The completed construction was set out to dry for at least 20 minutes before application
of the lysate.

Alginate Slab Preparation
Alginate slabs were prepared by depositing 1.5 mL of alginate mixed with X-gal onto a
polylysine coated slide and maneuvered in order to create a slab-like geometric shape. Through
several experiments, our team concluded that a wet-slab method was ideal for our application.
Following this method, once the initial slab was created, it was immediately cross-linked in 1.5%
CaCl2 for approximately 1 hour. This divalent cross-linker was chosen to create a uniform pore
size of approximately 3 nm, which is ideal for our application based upon the size of our enzyme
(ß-Galactosidase) and substrate (X-gal). Once cross-linking was completed, the slab was were
washed three times with 0.9% NaCl to stop all cross-linking activity and allowed to dry for 20
min. Prior to segmentation into the appropriate size for the sensor.61
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APPENDIX V: MILKGUARD INITIAL DESIGN
The initial design of the sensor contains three separate regions each with multiple layers
that can be seen in Figure 10.

(a)

(b)

Figure 10. Initial sensor design and region breakdown. The schematic of the layers that entrap the biomolecule
and makeup the sensor.62 The original sensor design is composed of three bands with various layers in each. (a)
displays the general concept of original sensor design, and (b) breaks down each band into the number of layers
deposited within it.

62

Morrison, Nina; O’Connor, Samantha; and Weber, Callie, "MilkGuard: Low Cost Paper Sensor for the Detection
of Escherichia coli in Donated Human Breast Milk" (2017). Bioengineering Senior Theses. 64.
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Table 12. Breakdown of each band deposited on the sensor and its corresponding layers.

Region

Layers

Region I

Layer 1: 0.5% poly(vinyl amine)
Layer 2: Silica sol-gel
Layer 3: FeCl3
Layer 4: Silica sol-gel

Region II

Layer 1: 0.5% poly(vinyl amine)
Layer 2: Silica sol-gel
Layer 3: X-Gus
Layer 4: Silica sol-gel

Region III

MSQ

0.5% poly(vinyl amine) (PVAM). The initial design utilized a thin coating of 0.5% of
PVAM at the base of Region I and Region II. This thin layer was used in order to
create a barrier between the silica sol-gel and the paper platform. Such a layer was
there in order to prevent the silica sol-gel from leaching into the paper platform to
preserve the integrity of the sensor itself.
Silica Sol-gel. As discussed in previous sections, the silica sol-gel layer was used to
entrap biomolecules and preserving such bioactivity.
Ferric Chloride (FeCl3). Ferric chloride acted as an oxidizing agent in order to
catalyze the reaction to produce a blue color change at a faster rate.
X-Gus. Previously, a nonpathogenic strain of E.coli (BL.21) was chosen as the cell
line in the experimental procedure with the idea that once the sensor was optimized, its
functionality could be applied to other contaminants. BL.21 have a specific enzyme
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ß-glucuronidase (GUS) that upon its reaction with the substrate
5-bromo-4-chloro-ß-D-glucuronide sodium salt (X-Gus), produces a blue color
indication.63
Methylsilsequioxane (MSQ). MSQ was used as a hydrophobic barrier in order to stop
the lateral flow of the sample. This concentrated the blue color change in Region II to
ensure for accurate readings that could be correlated to quantitative results.

APPENDIX VI: MILLER PROTOCOL
Instead of “lysing” the cell membranes, the Miller protocol permeabilizes the E. coli cells by
widening the pores of the membrane. The widening of the pores allow for ß-galactosidase to exit
the cell and furthermore mix with X-gal. The cells are permeabilized by adding 100 µl
chloroform and 50 µl 0.1% sodium dodecyl sulfate (SDS).64

APPENDIX VII: SIGNAL TO NOISE RATIOS
Our group compared signal to noise ratios of the five variables we selected as the most
significant in the experimentation. Such values can be seen in Figure 11 and were used to
establish which of the five variables created the best signal.
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Figure 11. Signal to noise ratios. The signal to noise ratios for the following variables were analyzed to determine
which produced the most significant signal in experimentation.
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